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ABSTRACT 
The in vitro biological properties of soy isoflavones suggest that they may 
negatively impact muscle growth in vivo. Three experiments were conducted to 
determine the impact of dietary soybean isoflavones on body and muscle growth in 
pigs and rats. In experiment one, pigs were self fed a basal diet containing 0 or 1585 
ppm supplemental isoflavones from 6 to 30 kg body weight. The isoflavones source 
consisted of an extract of soybeans that contained the isoflavones genistein, daidzein, 
and glycitein in relative proportions and physical forms similar to that present in 
soybeans. Isoflavones increased (P < .08) daily body weight gain (579 vs 595) and 
carcass muscle content (12.48 vs 12.87 kg). Increased muscle growth was observed 
in predominantly red-flbered muscles. In experiment two, pigs were fed diets that 
contained supplemental genistein concentrations of 0, 200,400, 600 and 800 ppm 
from 5 to 28 kg body weight. Serum genistein increased linearly (P < .01) from .55 
to 3.44 |iM as dietary genistein levels increased independent of stage of growth. 
Feed intake and body growth rate were decreased by dietary genistein during initial 
stages of growth, but were increased at later stages of growth in response to 
increasing dietary genistein. The combined weights of four red and four white 
muscles at 27 kg body weight, were not altered by dietary genistein concentration. In 
experiment three, gravid rats were fed a basal diet supplemented with 0, 431, 862 or 
1724 ppm isoflavones supplied by a soy extract similar to experiment one. Growth of 
male offspring was not altered by maternal dietary isoflavones but growth and 
efficiency of feed utilization of female offspring increased (P < .04) with increasing 
Xll 
maternal dietary isoflavone concentration. Hind limb muscle weights of male, but not 
female offspring, increased (P < .03) with increasing maternal isoflavone 
concentrations. Based on these data, dietary soy isoflavones increase muscle growth 
when fed either pre- or postnatally. Further, the inhibitory effects of genistein on 
muscle growth, which are observed in vitro at concentrations as low as 1.0 fiM, are 
not observed in vivo with serum concentrations as high as 3.4 ^iM. 
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CHAPTER 1. INTRODUCTION 
Economical production of pork is largely dependent on the muscle growth capacity 
and viability of the animals. Muscle growth is critical for efBcient pork production 
because deposition of a pound of muscle requires only 1.1 pounds of feed (com-soy 
diet) compared with 3.6 pounds of feed for deposition of a pound of fat tissue. 
Furthermore, muscle tissue has a market value 3 to 10 times that of fat tissue. Genetic 
selection for muscle growth in pigs has greatly increased the rate and extent of muscle 
growth in modem pig genotypes. Furthermore, it has increased the need to optimize 
other factors that influence expression of this genetic capacity for muscle growth. One 
of the most important factors is nutrition. Provision of the adequate quantity and proper 
balance of nutrients during pre- and postnatal growth is critical to allow muscle cells to 
proliferate and to fuel protein synthesis within muscle cells. Therefore, optimizing the 
pig's nutritional regimen is critical for economical pork production. 
Amino acids needs of modem pig genotypes are commonly met through the use of 
soybean products in pig diets (i.e. soybean meal, soy concentrates). In addition to 
providing vital nutrients, such as amino acids, carbohydrates, vitamins and minerals, 
soybeans contain non-nutritive factors (i.e. trypsin inhibitors, isoflavones) which may 
have either beneficial or detrimental effects on nutrient utilization and thus pig 
performance. Certain processing techniques (i.e. heat treatment) have been developed to 
inactivate certain factors such as trypsin inhibitor. However, a class of compounds 
known as isoflavones are not removed by typical processing techniques (i.e. heat 
treatment and solvent extraction) in the production of the most commonly fed soy 
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product, soybean meal. Isoflavones have been demonstrated to inhibit growth of 
cancerous cells in rodents. But the properties of isoflavones that are responsible for 
inhibiting cancer growth are also inhibitory for the growth and development of many 
normal cell types, specifically muscle and placental cells. Although several isoflavones 
exist in soybeans, and daidzein has been shown to inhibit growth of some cells, the 
biological properties of genistein in particular appear to be responsible for inhibiting cell 
growth. Genistein is a tyrosine kinase inhibitor. Tyrosine kinases are enzymes that 
regulate a plethora of cellular events. Recent in vitro studies have demonstrated that 
genistein inhibits critical processes required for muscle growth and decreases placental 
cell proliferation. Therefore, ingestion of genistein is hypothesized to alter the pig's 
capacity for muscle growth. Altematively, the isoflavone daidzein has been shown to 
stimulate glucose transport and immime cell proliferation. Quantifying the potential 
magnitude of genistein's and daidzein's effects on the rate and efficiency of muscle 
growth is critical in order to determine the relative value of employing new technologies 
such as identity preservation of soybeans based on their concentration and composition 
of isoflavones. 
Dissertation Organization 
The following dissertation is organized as a review of literature followed by three 
papers which are in the style and form of the Journal of Animal Science. The 
literature review examines muscle growth and development patterns both pre- and 
postnatally and the factors that influence these processes. Further, the review 
examines current literature on isoflavone distribution among plants, isoflavone 
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digestion, absorption, metabolism, and excretion in experimental human and animal 
models, and the biological effects of isoflavones on growth processes in mammalian 
cells. A brief discussion of research examining the effect of soybean saponins on 
animal growth is also included because saponins are difficult to separate from 
isoflavones in crude extracts that serve as isoflavone sources. The research reported 
in the three papers was conducted by Douglas R. Cook under the direction of Dr. Tim 
Stahly. Douglas R. Cook is the principal author of the papers and directed the 
execution of experimental procedures, data collection, statistical analysis, 
interpretation of data, and writing of the papers. A general conclusions section 
follows the last paper. 
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CHAPTER 2. REVIEW OF LITERATURE 
General Types and Patterns of Body Tissue Growth 
Reeds et al. (1993) used three categories in the context of defining growth: 
dimensional, compositional, and functional changes. Dimensional growth simply 
involves changes in mass and length and early studies focused on derivation of 
mathematical equations to describe dimensional growth of carcass and organs 
(McMeekan, 1940abc). The second form of growth simply describes the elemental 
and macromolecular accretion underlying dimensional changes. In its purest form it 
quantifies accretion only of elements (i.e. carbon, nitrogen, calcium, phosphorus). 
Accretion of elements is reflective of accretion of water, proteins, nucleic acids, and 
lipids that comprise body tissues. The third category of growth is defined by (Reeds 
et al., 1993) as "fundamentally a problem of understanding the regulation of genetic 
expression". Modem growth biologists focus on understanding mechanisms that 
regulate gene expression as it relates to cell proliferation and protein synthesis and as 
it relates to activation of genes themselves. Therefore, a succinct yet encompassing 
definition of growth is difficult. Reeds et al. (1993) suggested that there are as many 
different definitions of growth as there are growth researchers. Grant and Helferich, 
(1991) defined growth as the increase in size and changes in functional capabilities of 
the various tissues and organs of animals that occurs from conception through 
maturity. Hedrick et al. (1994) defines growth as a normal process of increase in size, 
produced by accretion of tissues similar in constitution to those of the original tissue 
or organ. These authors also distinguish between true growth and fattening and 
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suggest that true growth is an increase in structural tissues such as muscle, bone, and 
vital organs. Fattening is essentially an increase in adipose tissue. Both processes fit 
within the definition of growth but should be considered separately when applied to 
animal production (Hedrick et al., 1994). But, this definition does not distinguish 
between normal adipose tissue accretion during the growth phase fi'om conception to 
maturity and adipose tissue accretion after physiological maturity. Thus, it inherently 
requires one to define or quantify physiological maturity, which is difficult to do. 
Moreover, if adipose tissue accretion prior to physiological matimty is considered 
part of normal growth, then it stands to reason that the quantity of adipose tissue 
accrued would have to be defined under a given set of environmental circumstances 
(i.e. temperature, amino acid adequacy, dietary fat level). Therefore, the distinction 
between true growth and fattening is ambiguous. Thus, the definition of Grant and 
Helferich, (1991) seems to be the most appropriate definition of growth for this 
discussion. 
The growth of tissues relative to one another and the progression from a low to 
high stage of complexity (i.e. progression of embryo from single cell to an organism 
with multiple organs) is defined as development. McMeekan (1940c) quantified 
growth in the pig from birth to 28 weeks of age and described pattems of growth in 
carcass tissues of muscle, fat, skin, and bone. Growth of individual organs was 
quantified separately but categorized into alimentary tract organs (esophagus, 
stomach, small intestine, caecimi, and large intestine and rectum) and abdominal 
organs (mesentary, liver, gall bladder, spleen, pancreas, kidneys, leaf and kidney fat 
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and bladder). However, conclusions were based on expressing tissue weights as a 
percentage of their respective weights at birth (McMeekan, 1940c). Using this 
method, fat appears to be the first tissue to develop relative to muscle, bone and skin 
because fat has the greatest percent increase in weight due to a very small weight at 
birth. But actual grams of fat accrued from birth to four weeks of age are only half 
that of muscle accrued. Thus, if tissue weights are expressed as a percentage of their 
respective weights at an ending point, 28 weeks in this case, a more accurate picture 
of relative growth rates can be obtained. In the carcass, bone develops first accruing 
10 and 70 percent of its weight by four and 20 weeks, respectively. Skin follows a 
similar pattern, and muscle develops next accruing 6 and 56 percent of its weight by 
four and 20 weeks, respectively. Fat tissue accrues 3 and 38 percent of its weight by 
four and 20 weeks, respectively. The alimentary tract accrues 9.5 and 87 percent of 
its weight by four and 20 weeks, respectively while the abdominal organs accrue 6.4 
and 60 percent of their weight by four and 20 weeks, respectively. Collectively, these 
data indicate that relative to their weights at 28 weeks of age, organs of the alimentary 
tract are the first to develop followed in order by bone, skin, abdominal organs, 
muscle, and fat. 
Postnatally, growth of muscle is accomplished via hypertrophy of individual 
muscle fibers concurrent with hyperplasia of satellite cells. The simultaneous 
occurrence of these two processes, which will be discussed below, is the cornerstone 
of postnatal muscle growth (Allen et al., 1979). 
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Overview of Muscle Structure and Function 
Skeletal muscle is primarily a locomotive tissue that allows animals to stand and 
move from one point to another. Muscle development begins when muscle-specific 
genes are expressed in embryonic cells which then begin to proliferate and migrate 
throughout the embryo (Epstein and Berstein, 1992). Muscle growth is complete 
when an animal reaches mature body size. But even at mature body size, protein 
degradation and synthesis are occurring and muscle is in a constant state of flux. 
Depending on an animal's nutritional status, environmental conditions, and 
physiological state (i.e. gestation, lactation), muscle may be degraded and its 
components (i.e. amino acids, lipids) used as an energy source, or incorporated into 
other body products (i.e milk, acute phase proteins). Therefore, muscle can serve as 
source of energy and meet amino acids needs for important body processes in 
addition to providing a means of locomotion. 
Chemically, skeletal muscle is 65-80% water, 16-22% protein, 1.5-13% lipid, 0.5-
l .3% carbohydrate, and contains many anions and cations important to physiological 
function such as calcium, phosphorus, sodium, magnesium, and chlorine (Hedrick et 
al., 1994). The contractile filaments of muscle, myofibrils, are contained within 
multinucleated cells, called fibers, and have no membrane but exist because their 
proteins are insoluble at the ionic strength of muscle. Each myofibril is composed of 
more than 20 proteins arranged in a highly ordered and repetitive manner to achieve 
contractile fimctionality. Individual fibers are immediately surrounded by 
sacrolemmal membranes and further by endomysial membranes. Fibers are arranged 
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in bundles that are surrounded by the perimysial membranes and many bundles are 
contained within each of the body muscles which are surrounded by epimysial 
membranes (Hedrick et al., 1994). 
The proteins of skeletal muscle are broadly classified according to their solubilities 
into three categories. Sarcoplasmic proteins include myoglobin and enzymes 
associated with the TCA cycle and glycolysis and are soluble at low ionic strength. 
Myofibrillar proteins include the main contractile proteins actin and myosin and are 
soluble only at higher ionic strengths. The stromal proteins include connective tissue 
proteins and are not soluble in salt solutions. Based on these properties sarcoplasmic, 
myofibrillar, and stromal proteins can be rapidly separated via simple techniques thus 
allowing evaluation of their properties in vitro. 
Muscle Development (Myogenesis) 
Myogenesis is a multistep process that chronologically involves the following 
processes: 1. Progenitor cell determination to the myogenic lineage; 2. Migration of 
myogenic stem cells (myoblasts) to appropriate locations in the early embryo; 3. 
Proliferation of myoblasts; 4. Terminal myocyte differentiation and expression and 
organization of specific gene products active only in terminally-differentiated muscle 
cells; 5. Maintenance of the terminal differentiated state and modulation of myo fibers in 
various myofiber types in response to age and physiological cues (Te Pas and Visscher, 
1994). Progenitor cell determination and migration will be discussed together because 
these two processes occur simultaneously. Proliferation of myoblasts and terminal 
differentiation also will be discussed together because peptide growth factors are key 
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regulator of both processes and some have opposing actions on proliferation and 
differentiation while others have concentration-dependent biphasic effects. 
Progenitor Cell Determmation and Migration 
Skeletal muscle is presumed to originate exclusively from mesoderm during 
vertebrate embryogenesis (Sassoon, 1993). Somites, which represent the first metameric 
units of the embryo, are derived from the mesoderm and are generally accepted to be the 
source of all skeletal muscle (Chevallier et al., 1977; Christ et al., 1977). During early 
embryogenesis, the dorsal aspect of somites compartmentalizes into a structure known 
as the dermamyotome. This stage of somitogenesis is coincident with migration of cells 
from the somite into the body of the embryo and a subset of these cells are committed 
myoblasts (Chevallier et al., 1977) which colonize structiu"es such as the limbs, 
depositing founder populations that will generate mature skeletal muscle. However, at 
the time myoblasts begin to migrate from the somites to limb buds, the proteins thought 
to be responsible for myogenic determination (myogenic regulatory factors or MRFs) 
cannot be detected in the myoblasts, although mRNA for one of the MRFs has 
accumulated (Cusella-De Angelis et al., 1992; Sassoon, 1993). These data suggest that a 
population of myoblasts exists that is not dependent on MRF expression for lineage 
commitment although MRF expression occurs within 12 hours after migration begins. 
The physiologic cues responsible for commitment to the myogenic lineage, in the 
absence of MRF expression, have not been elucidated. 
Myogenic Regulatory Factors 
Myogenesis and commitment to the myogenic lineage in the developing embryo are 
induced through expression of a set of genes known as the MyoD family (Olson, 1992). 
This gene family consists of several distinct myogenic regulatory factor (MRF) genes 
including myfS, MRF4, myogenin and myoD (Sassoon, 1993). The first, and most 
dramatic, demonstration of their function showed that stable transfection of a cDNA 
coding for a helix-loop-helix protein, later designated as MyoD, into lOTl/2 fibroblasts 
could invoke the myogenic program (Lassar et al., 1986) suggesting that these factors do 
mediate commitment to the myogenic lineage. Their fiinctions appear to overlap 
because transfection of any one of these genes into fibroblasts is sufficient to initiate the 
myogenic program (Edmondson and Olson, 1993). Induction of myogenin can be 
blocked with a myogenin antisense oligodeoxyribonucleotide mRNA (Florini and 
Ewton, 1990) which has the ultimate effect of blocking myoblast differentiation. These 
data demonstrate that expression and activity of myogenin are critical for muscle cell 
differentiation. It is also clear that MRFs can promote transcription of several muscle-
specific genes including creatine kinase and myosin (Buskin and Hauschka, 1989; 
Wentworth et al., 1991). At the present time, it is not clear why four MRFs exist and 
whether they represent redundancy or each have separate and essential functions. Mice 
lacking MyoD have normal skeletal muscle, are fully viable and do not exhibit obvious 
defects. The only molecular difference is that levels of myf-5 are slightly elevated 
relative to wild type mice (Rudnicki et al., 1993). However, critical functions appear to 
be associated with certain MRF genes as demonstrated by gene knockout experiments. 
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Mice lacking Myf5 show an unanticipated phenotype in which their ribs are totally 
absent or are severely truncated (Braun et al., 1992). Further characterization of this 
model reveals markedly delayed development of paraspinal and intercostal muscles 
(Kablar et al., 1997). In contrast, MyoD deficient mouse embryos have normal 
paraspinal and intercostal muscle development but delayed limb bud muscle 
development. Knock-in experiments in which the Myf-5 locus is replaced with 
myogenin show that myogenin can replace MyfS without negative effects (Wang and 
Jaenisch, 1997). But if both myoD and MyfS are knocked out, myogenin expressed 
from its own locus and Myf5's locus cannot rescue myogenesis. Taken together, these 
data suggest that MyoD and Myf-5 have unique but overlapping roles in muscle 
development. Current studies are focusing on other transcription factors which regulate 
the expression and activity of MRFs (Hamamori et al., 1997; Kong et al., 1997; 
Lemercier et al., 1998). 
The flmction, and thus classification, of MRFs can be discussed relative to their roles 
in stem cell determination versus myoblast differentiation. Myf-5 and MyoD are 
expressed in myoblasts before differentiation and are required for the determination of 
muscle progenitor cells whereas myogenin is expressed upon differentiation and is 
required in vivo as a differentiation factor (Megeney and Rudnicki, 1995; Megeney et 
al., 1996). The role of MRF4 remains unclear. The role of MRFs in vertebrate 
embryogenesis is reviewed by Sassoon, (1993), and Rudnicki and Jaenisch, (1995). 
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Intracellular Signals 
Protein kinase A (PKA), and factors which alter its cellular concentration, exert an 
effect on myogenesis. Cholera and pertussis toxins, which increase and decrease cAMP 
concentrations, respectively, and thus PKA activity, exert opposite effects on 
myogenesis and specifically, the accumulation of MRFs. Kelvin et al. (1989) and 
Salminen et al. (1991) both demonstrated that cholera toxin inhibits MRF expression 
while pertussis toxin promotes MRF expression. Hu and Olson, (1988) showed that the 
muscle cell line BC3HI, has myogenesis regulated by a cAMP-dependent pathway, and 
that cAMP inhibits differentiation of this cell line. Furthermore, Winter et al. (1993) 
demonstrated that PKA represses myogenic differentiation and the activity of the 
transcription factors Myf-5 and MyoD. Collectively, these reports demonstrate that 
myogenesis is regulated, at least in vitro, via a PKA-dependent pathway. 
Myogenic Cell Proliferation and Terminal Myocyte Differentiation: Peptide 
Growth Factors 
Through the use of recombinant DNA technology, peptide growth factors have 
become available that are highly purified and affordable. This has allowed their use 
extensively in cell culture systems to study mechanisms of muscle cell growth and 
differentiation. Insulin-like growth factors-I and 11 (IGF-I and IGF-II) are unique 
among growth factors in that they stimulate both proliferation and differentiation of 
many myogenic cell types (Florini et al., 1991a). Myogenic cells that are 
mitogenically responsive to IGFs are derived from many species which include 
chicken (Duclos et al., 1991), rat (Dodson et al., 1985), bovine (Greene and Allen, 
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1991), turkey (McFarland et al., 1993) and porcine (Doumit et al., 1993). In cultured 
myogenic cells, IGFs invoke the myogenic program through induction of myogenin 
expression (Florini et al., 1991b). While IGF's are capable of myogenic program 
induction through MRP expression, most other peptide growth factors studied in 
myogenic systems are inhibitory to MRF expression or activity. Basic fibroblast 
growth factor (bFGF) and transforming growth factor beta (TGF-/9) are both well-
documented, potent inhibitors of myogenesis (Lathrop et al., 1985; Florini et al., 
1986; Massague et al., 1986; Allen and Boxhom, 1987; Johnson and Allen, 1990; 
Hathaway et al., 1991). Basic FGF stimulates most myogenic cells to proliferate 
while its blocks their differentiation thus increasing the number of cells in a 
proliferative state. More recent evidence suggests that bFGF may have a biphasic 
effect stimulating differentiation at low concentrations and inhibiting it at high 
concentrations (Pizette et al., 1996). The effects of TGF-^ are less clear though. 
TG¥-/3 generally blocks differentiation (Massagueet al., 1986) while its effects on 
proliferation of myogenic cells range from inhibition, to no effect, to stimulation 
(Johnson and Allen, 1990; Pampusch et al., 1990; Greene and Allen, 1991; Cook et 
al., 1993). TGF-/3 and bFGF block differentiation via protein kinase C induction, 
which phosphorylates the DNA binding site making it unavailable for MRF binding 
(Olson, 1992). Platelet-derived growth factor-BB (PDGF-BB) is a potent mitogen for 
many myogenic cells including chick myoblasts (Yablonka-Reuveni and Seifert, 
1993), rat myoblasts (Jin et al., 1990; Yablonka-Reuveni et al., 1990; Jin et al., 1991), 
and turkey (McFarlandet al., 1993), and porcine satellite cells (Doumitet al., 1993). 
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Its effect on differentiation is similar to that of bFGF and TGF-P in that it inhibits 
differentiation of myogenic cells (Jin et al., 1991). 
Maintenance of the Terminal Differentiated State: Muscle Fiber Development 
In pigs, fiber number is determined before birth (Allen et al., 1979), possibly by 90 
days gestation (Wigmore and Stickland, 1983). Early in gestation (day 18-20 in the 
pig), embryonic stem cells differentiate into myoblasts which continue to proliferate 
until they receive the necessary cues for differentiation. Upon receiving the 
necessary signals, myoblasts begin to fuse with each other forming long, 
multinucleated myotubes which will become the first muscle fibers. These fibers are 
termed "primary" fibers and serve as a structural fi-amework upon which all 
subsequent fibers (secondary fibers) form . Myotube formation marks a critical 
transition for myoblasts in that they become post-mitotic once incorporated into 
myotubes. However, a population of myoblasts, termed satellite cells, always exists 
outside the muscle fibers and thus retains the ability to proliferate. This population 
serves as the source of cells which forais all subsequent myotubes and ultimately 
myofibers. Postnatally, DNA contained within the cytoplasm of muscle fibers is 
postmitotic or terminally differentiated. Thus, satellite cells are critical for addition 
of new nuclei to muscle fibers. The size of this myoblasts pool, which is determined 
by the proliferation rate, is vital to sustaining muscle development. The larger the 
pool size of myoblasts cells, the larger the potential for myofiber formation. 
Evidence for this phenomenon (large myoblast pool size) is displayed in response to 
selection for muscling in a variety of species. Quinn et al. (1990) isolated myogenic 
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cells from normal and double muscled cattle embryos. Cells from the double muscled 
cattle exhibited delayed onset of ftision which resulted in a greater number of 
proliferating myoblasts and ultimately a greater number of myotubes in vitro. This 
phenomenon likely helps to explain the increased muscle mass observed in cattle with 
this trait. Delayed fiision is also observed in a turkey model which compared a 
commercial variety of turkey to a wild type and found that the heavier-muscled 
commercial variety possessed satellite cells which were slower to initiate ftision in 
culture (McFarlandet al., 1993). Although satellite cells are a posmatal cell type, it is 
likely that they possess properties of their prenatal myoblast ancestors (slower fiision 
thus allowing for ftirther proliferation and an increase in the population of myogenic 
cells). A quail model also has been used to study developmental differences between 
birds selected over several generations for muscle growth and the unselected controls. 
Coutinho et al. (1993) used an in situ hybridization technique and showed that select 
line quail exhibit delayed expression of myogenic regulatory factor genes which play 
a critical role in fiision initiation. This would likely allow proliferation to occur 
longer prior to ftxsion initiation and the transition to a post-mitotic state. These three 
studies give independent lines of evidence that heavy muscled animals have 
myogenic cells which initiate differentiation later in development than cells from 
normal animals, and likely serve to increase the population of mononucleated cells 
which in turn support greater myotube and myofiber formation in vivo. Greater 
muscle fiber number at birth forms the basis for increased muscle growth potential 
postnatally. 
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Muscle Fiber Number and Muscle Growth Potential 
Quantification of muscle fiber number, coupled with estimation of muscle growth 
rate, has demonstrated that muscle fiber nvimber at birth is a critical factor in 
determining the subsequent capacity for muscle growth (Dwyer et al., 1993; Dwyer et 
al., 1994). Specifically, greater fiber numbers result in greater muscle growth. 
Furthermore, fiber quantification in runt and normal pigs has demonstrated that runt pigs 
bom with reduced fiber numbers have reduced muscle growth potentials while runt pigs 
bom with higher fiber numbers exhibit growth rates similar to normal littermates 
(Handel and Stickland, 1988). Collectively, these reports indicate that skeletal muscle 
fiber number influences postnatal muscle growth potential. 
In addition to greater rates of body and muscle growth, efficiency of feed utilization 
for body weight gain also is greater in pigs with greater muscle fiber numbers (Dwyer et 
al., 1993; Dwyer et al., 1994). Furthermore, pigs with a high capacity for muscle growth 
postaatally derived via genetic selection, low antigen exposure, or administration of 
growth promotants (Bark et al., 1992; Williams et al., 1997) grow faster, require less 
feed per imit of growth and produce bodies that possess less fat tissue and more muscle. 
Thus, factors that inhibit muscle cell formation and subsequent muscle cell growth 
(satellite cell incorporation) are hypothesized to lower pig growth rates, efficiencies of 
feed utilization for growth and carcass value due to the reduction in carcass muscle 
content relative to fat. A more detailed description of muscle fiber development 
prenatally and the role of satellite cells in postoatal muscle growth is outlined below. 
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Role of Satellite Cells in Postnatal Muscle Growth 
In addition to possessing greater fiber numbers, heavy muscled animals are also to 
known to have greater quantities of DNA per muscle (Robinson and Bradford, 1969; 
Powell and Aberle, 1975; Aberle and Doolittle, 1976; Harbison et al., 1976; reviewed by 
Allen et al., 1979). This is easily rationalized due to the fact that myofibers are formed 
in the embiyo via fusion of myoblasts, and therefore, greater fiber number would 
correspond to greater quantities of DNA. However, the vast majority of skeletal muscle 
DNA (up to 95% in some species) is accumulated posmatally via the proliferation and 
fusion of myogenic satellite cells, after myofiber formation is complete (Allen et al., 
1979). Satellite cells are similar to embryonic myoblasts in that they reside outside 
muscle fibers, prohferate and subsequently fuse with existing muscle fibers. Differences 
in postnatal DNA content per muscle between animals which differ in muscularity must 
therefore, be largely due to differences in satellite cell proliferation and subsequent 
flision into existing muscle fibers. In support of this hypothesis, studies have 
demonstrated that 1) sera from heavy muscled pigs stimulate greater in vitro 
proliferation of cultured myogenic cells than serum from lighter muscled pigs (Allen et 
al., 1982), 2) lean gain per day is positively correlated with in vitro serum mitogenic 
activity (Cook et al., 1992) and 3) in vivo proliferative capacity of satellite cells is higher 
in lean mice than in obese mice (Purchas et al., 1985). These studies suggest that 
satellite cell proliferation and subsequent fusion play a critical role in postnatal muscle 
growth. 
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In addition to correlational data, studies which utilized treatments that inhibited DNA 
accumulation provide more evidence that skeletal muscle DNA accretion is vital to 
muscle growth. Young rats which were nutritionally restricted had decreased amounts 
of DNA per muscle. When realimented, these animals did not accumulate normal 
amounts of muscle DNA nor normal muscle weights (Winick and Noble, 1966). 
However, an older group that was restricted after attaining maximum DNA per muscle, 
did regain normal muscle weights following realimentation. The implication of this 
study is that DNA accretion is a prerequisite for normal muscle growth since only those 
animals that already possessed maximum DNA per muscle were able to attain maximum 
muscle weights upon realimentation. Swatland and Cassens, (1974) showed that pigs 
fed a maintenance diet had impaired skeletal muscle DNA accumulation and no muscle 
growth. Moss, (1968) showed that a 2 day starvation period, from 7 to 9 days of age, 
severely retarded both muscle growth and DNA accumulation in breast muscle of 
chickens. Subsequent refeeding did not restore these values to those of control animals 
by 27 days of age. However, the ratio of muscle weight to nuclei number was the same 
between control animals and starved-refed animals. These data indicate that the 
proliferative activity of satellite cells is sensitive to the animals nutritional status and is 
vital to achieve maximum lean mass and growth potential of these animals. 
The studies discussed above indicate that satellite cell proliferative activity is an 
important factor in determining muscularity. Differences in muscularity could, 
therefore, occur due to differences in satellite cell proliferation and differentiation with 
no differences in the actual population size of satellite cells. Alternatively, if satellite 
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cell proliferative activity is constant, increases in the population size would increase 
skeletal muscle DNA. For example, if animal "A" possesses 10*^ nuclei per muscle 
while animal "B" possesses 5X10^ nuclei per muscle, and proliferative rate is constant, 
then animal "A" will provide that muscle with twice the nuclei each round of 
proliferation (assuming differentiation did not differ). The greater the population of 
satellite cells dividing and fiasing, the greater the cellular machinery (DNA) that would 
be available to support protein synthesis. Differences in satellite cell populations in the 
absence of proliferation differences have not been tested due to the difficulty in 
histologically distinguishing satellite cell nuclei fi-om postmitotic myofiber nuclei. 
However, it is reasonable to suggest that a larger satellite cell population would support 
greater muscle growth (Doumit et al., 1996). 
Strategies aimed at increasing the population of satellite cells will likely increase 
carcass muscle mass, muscle growth potentials and efficiencies of feed utilization for 
growth. However, the exact mechanism through which satellite cells develop is 
equivocal. Satellite cells are thought to be a population of adult myoblasts which 
develop during the late fetal period and have not fused prior to birth (Stockdale, 1992). 
If this is correct, altering the population of myoblasts during the fetal period may have 
two effects: 1) to alter the cells available to form muscle fibers and therefore alter fiber 
number prenatally, and 2) to alter the population of postnatal satellite cells available for 
fusion into existing myofibers (assuming a constant proportion of the prenatal myoblast 
pool remains undifferentiated prior to birth). 
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Muscle Fiber Types 
The fibers of skeletal muscle are not homogeneous. Several classification schemes 
have been used to describe their contractile speed (Guth and Samaha, 1969), metabolic 
capabilities (Dubowitz and Pearse, 1960; Beecher et al., 1965; Cooper et al., 1970), and 
visual or histochemical appearance (Needham, 1926; Handel and Stickland, 1987; 
Solomon and Montgomery, 1988). In general, three major fiber types are recognized to 
exist and are designated via the following schemes: types A, B, and C (Stein and 
Padykula, 1962), types I, HA, and HB (Dubowitz and Pearse, 1960) and types PR, aW, 
and aW (Ashmore and Doerr, 1971). White fibers can be equated with type A, IIB and 
aW; red fibers are equivalent to type B, I and PR; intermediate fibers are synonymous 
with type C and ELA and aR (Solomon and Montgomery, 1988). The simplest scheme is 
to designate muscles as red, white, or intermediate based on their appearance (Hedrick et 
al., 1994) which is a function of the proportion of red versus white versus intermediate 
fibers contained there in. The intensity of red color within a fiber is a fianction primarily 
of the myoglobin content of the fiber. However, this classification grossly 
oversimplifies many differences between red, white, and intermediate fibers. Others 
have subdivided categories thus allowing fluther classification into four (Maltin et al., 
1989) and as many as eight distinct fiber types (Morita et al., 1970). A brief summary of 
relative differences in the three main distinct fiber types is presented in Table 1. 
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Table I. Characteristics of red, intermediate, and white muscle fibers in domestic meat 
animals and birds®. 
Characteristic'' Red Fiber Intermediate Fiber White Fiber 
Color red red white 
Myoglobin content high high low 
Fiber diameter small small-intermediate large 
Contraction Speed slow fast fast 
Contractile Action tonic tonic phasic 
Mitochondria no. high intermediate low 
Mitochondria size large intermediate small 
Capillary density high intermediate low 
Oxidative metabolism high intermediate low 
Glycolytic metabolism low intermediate high 
Lipid content high intermediate low 
Glycogen content low high high 
Z disk width wide intermediate narrow 
®Adapted firom (Hedricket al., 1994). 
''Characteristics are relative to the other fiber types. 
Relative contractile speed is determined histochemically by assaying the stability of 
myosin ATPase present in different fibers. The ATPase of red fibers is acid labile and 
base stable while the ATPase of white fibers is acid stable and base labile. Intermediate 
fibers have a myosin ATPase that is intermeidate in stability at both acidic and basic pH 
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values (Guth and Samaha, 1969). Therefore, relative amounts of each myosin ATPase 
within muscle fibers can be elucidated by observing staining intensities in varying 
hydrogen ion concentrations. Oxidative versus glycolytic metabolism also can be 
assessed histochemically by quantifying relative staining intensities for oxidative 
enzymes such as succinic dehydrogenase (Beecher et al., 1965) versus glycolytic 
enzymes such as phosphorylase (Maltinet al., 1989). Other differences between fiber 
types include greater numbers of glucose transporters (GLUTl and GLUT4) present in 
red versus white fibers, and thus, greater maximal velocity of glucose transport per unit 
of muscle tissue (Goodyear et al., 1991). But the intrinsic activity of glucose 
transporters does not appear to differ between red and white fibers. Rates of protein 
turnover are higher in muscles with a high proportion of red fibers versus white fibers 
(Garlick et al., 1989). Greater glucose transport capacity in red fibers could reflect a 
greater energetic requirement based on greater rates of protein synthesis. 
Porcine muscles are unique in that red fibers are located at the center of a bundle 
of fibers and are surrounded by white and intermediate fibers (Davies, 1972). Red 
fibers are thought to arise almost exclusively firom primary fibers while secondary 
fibers give rise to intermediate and white fibers. This arrangement of fibers allows 
estimation of ratio of primary to secondary fibers in a mature animal which is related 
to muscle mass (Dwyer et al., 1993; Dwyer et al., 1994). 
Estrogenic Effects on Growth 
Estrogenic compounds have been extensively studied in ruminants because of their 
anabolic effects which include improved daily body weight gain, efficiency of feed 
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utilization, and increased rates of muscle, bone, and conncetive tissues (for review see 
Hancock et al., 1991). Estrogen administration also decreases subcutaneous and 
intramuscular fat accretion in ruminants. Much less data exist in pigs, presumably 
because the effects are small and inconsistent. Boars implanted with estrogen 
consume more feed, gain body weight faster and have improved feed/gain ratios 
compared with control males (Teague et al., 1964; Plimpton and Teague, 1972; 
Newell et al., 1973; Galbraith and Topps, 1981). But carcass percent fat is increased 
and percent carcass protein is decreased. The responses appear to be a result of 
increased feed intake and thus, carcass fatness is increased. However, a more recent 
study with higher doses of estrogen increased gain 15-30% without increasing carcass 
fatness appreciably compared with control intact males (Anderson et al., 1988). 
Boars in the second study were likely genetically leaner animals and thus, capable of 
using increased energy for protein accretion whereas boars in the first study were 
likely genetically fatter and thus increased energy intake would be directed toward fat 
accretion. Mixed results have been observed when barrows and gilts are administered 
estrogen but the trend is for very few beneficial effects (Dinusson et al., 1951; 
Pearson et al., 1952; Galbraith and Topps, 1981). Moreover, estrogens increase udder 
development in barrows and gilts thus reducing the value of the belly. In castrated 
male, intact male and female rats, estrogen administration over a wide range of doses 
results in decreased feed intake and thus decreased body weight gain (Moffit et al., 
1975). Based on these data, ruminants respond positively to estrogen administration. 
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boars respond by increasing feed intake, barrows and gilts respond very little, and rats 
respond negatively. 
Comparative Aspects of Pigs and Rats: Placentas 
The placenta is a critical organ in that it supplies nutrients to the developing fetus. 
In chapter 5, gravid rats are used to study the effect of a known inhibitor of placental 
growth on subsequent outcome of rat pups. Species-based differences in placental 
structure might influence fetal response to dietary compounds. Therefore, a brief 
discussion on comparative aspects of placentas in the model species (rat) and the 
species of interest (pig) is pertinent. 
Four aspects of placental structure are commonly used for comparative purposes; 
shape, patterns of matemofetal interdigidation, layering of interhemal membranes, 
and patterns of bloodlfow (Leiser and Kaufinann, 1994). The pig has a diffuse 
placental shape in which the entire surface of the chorionic sac contacts the maternal 
uterine tissue (MacDonald and Bosma, 1985) which results in a large and diffuse 
exchange area for nutirents. In contrast, rats have the highest degree of concentration 
of exchange tissue termed discoidal placenta (Enders, 1965; Kaufmann and Davidoff, 
1977; Ramsey, 1982). The discoidal placenta forms a "placental disc" which results 
in nutrient transfer occurring in one concentrated area as opposed to a large diffuse 
area as in the pig. 
Interdigitation of maternal and fetal tissues is critical for nutrient transfer to occur. 
Pigs have the simplest type of contact called the folded type in which ridges of 
uterine mucosa and fetal chorion interdigitate (MacDonald and Bosma, 1985). Rats 
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have the most sophisticated type of matemo-fetal tissue interrelation represented by 
the labyrinthine placenta (Kaufinann and Davidoff, 1977) in which the chorion is 
penetrated by web-like arranged channels, 50% of which are perfused with maternal 
blood. The remaining channels contain fetal capillaries. 
The most prominent classification system for placental types is the Grosser system 
which describes the type and number of tissue layers separating maternal and fetal 
blood (Leiser and Kaufinann, 1994). Again, pigs have the most simple type called 
the epitheliochorial placenta. The fetal chorion covered by trophoblast is attached to 
a more or less intact uterine mucosa (MacDonald and Bosma, 1985). This type of 
implantation is referred to as superficial because tme endometrial invasion does not 
occur. Six tissue layers separate maternal and fetal blood: matemal endothelium, 
connective tissue, matemal epithelium, trophoblast, fetal connective tissue, and fetal 
endothelium (Leiser and Kaufinann, 1994). Other placental types actually invade 
uterine tissue, progressively destroy successive matemal tissue layers, and thus 
decrease the number of layers separating fetal and matemal blood. The rat has a 
hemotrichorial placenta in which the blastocyst has invaded through the matemal 
epithelium, connective tissue, and endothelium directly exposing the chorion to 
matemal blood. The "tri" signifies three layers of trophoblast still exist (Enders, 
1965). It might be assumed that the greater the number of tissue layers nutrient have 
to travel across, the less effective the placentation is. This is not the case (Faber and 
Thomburg, 1983) and evidence against this supposition is provided by examination of 
fetal vs placental birth weights (Dantzer et al., 1988). One gram of the pig placenta 
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(six-layered interaction) supports nine grams of fetus at birth whereas a gram of 
human hemomonochorial three-layered placenta supports only six grams of fetal 
weight at term. Part of the discrepancy can be explained by the fact that the thickness 
of the three-layered hviman placenta is the same thickness as the six-layered barrier of 
the pig (Leiser and Kaufinann, 1994). 
The fourth aspect of placental structure is the arrangement of fetal and maternal 
blood flow relative to one another. Concurrent flow systems in which fetal and 
maternal blood flows in parallel and in the same direction are the least efficient and 
does not exist in mammals (Martin, 1981). The most efficient arrangement is the 
countercurrent flow in which the blood flow of dam and fetus are parallel to one 
another but flow in opposite directions. Rats possess this type of arrangement 
(Kaufinann and Davidoff, 1977; Dantzeret al., 1988) and thus have very small 
placentas in relation to the fetal weight supported. The pig has a less efficient double 
crosscurrent flow which is intermediate between the two systems mentioned above 
(Dantzer et al., 1988). The importance of this classification system for fetal oxygen 
supply is supported by the observation that animals with a less efficient vessel 
arrangement have a decreased feto-placental weight ratio at term (pig 9:1; cat 8:1; 
human 6:1) versus the highly efficient and small (20:1) rodent placentas (Dantzer et 
al., 1988). 
Flavonoids 
Flavonoids are a group of polyphenolic compounds diverse in chemical structiu-e 
and biological activities. Their structure is based on the flavan nucleus and the three 
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phenolic rings are referred to as pyrane rings. Biological activity depends on 
chemical structure and relative orientation of various moieties on the molecule 
(Kurzer and Xu, 1997). Flavonoids occur naturally in fioiits, vegetables, nuts, and 
seeds. When consumed by mammals, flavonoids are digested, absorbed, metabolized 
and excreted. Over 4,000 different flavonoids have been identified within eight major 
classes which include flavonols, flavones, flavonones, catechins, anthocyanidins, 
isoflavones, dihydroflavonols, and chalcones (Cook and Samman, 1996). Because of 
flavonoids' wide plant distrubution and diverse chemical structure, a myriad of 
biological activites have been documented (Cook and Samman, 1996). Therefore, a 
discussion of biological actvities will be limited to the flavonoid class of interest, 
isoflavones. 
Isoflavones: Chemical Structure 
The generic structure of isoflavones is shown in Figure 1. Substitutions at various 
locations on the isoflavone molecule result in three distinct aglycone isoflavones 
referred to as genistein, daidzein and glycitein. Further glucosidic substitutions 
(Figure 2) result in three conjugated forms of each aglycone isoflavone. 
Plant Distrubution 
Although flavonoids are found in a vast numbers of plants, vegetables and flowers, 
isoflavones are found in just a few botanical families. This is because of the limited 
distribution of the enzyme chalcone isomerase, which converts 2(R)-naringinen, a 
flavone precursor, into 2-hydroxydaidzein. This enzyme is found primarily in 
Compounds Rl R2 R3 
Daidzein OH H H 
Genistein OH H OH 
Glycitein OH 0CH3 OH 
Figure 1. Chemical structure of the aglycones genistein. daidzein and glycitein 
tropical legumes (Coward et al., 1993) and as a result, high concentrations of 
isoflavones are most commonly found in soybeans (Wang and Murphy, 1994), 
soybean products (Coward et al., 1993; Barnes et al., 1994; Wang and Murphy. 
1994), and other legumes such as subterranean clover (Smith et al., 1986). Because 
protein products derived from soybeans are widely used in pig diets, differences in 
isoflavone levels that exist in specific soy products, as a result of various soy 
processing techniques, will influence isoflavone levels in pig diets. In addition, 
variation exists in soybean isoflavone levels as as result of soybean variety (2344 vs 
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CHzOR, 
HO 
HO R 
OH 
Compounds Ri Rj R3 
Daidzin H H H 
Genistin OH H H 
Glycitin H 0CH3 H 
6"-0-AcetyIdaidzin H H COCH3 
6"-0-acetylgemstin OH H COCH3 
6"-0-acetylglycitin H OCRs COCH3 
6" -0-Malony Idaidzin H H COCH2COOH 
6" -0-Malony Igenistin OH H COCH2COOH 
6"-0-Malonylglycitin H OCH3 COCH2COOH 
Figxire 2. Chemical structure of glycosylated forms of isoflavones. 
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4216 mg/kg), crop year (2776 vs 3309 mg/kg), and growing location (1176 vs 1749 
mg/kg) (Wang and Murphy, 1994). Others have reported similar results (Eldridge 
and Kwolek, 1983; Farmakalidis and Murphy, 1985). One variety of soybeans 
(Maple Arrow) has been reported to contain 8000 mg/kg isoflavones (Kudou et al., 
1991). 
Variation in isoflavone levels due to soy product processing is evidenced by the 
following hierarchy of isoflavone concentrations: soybeans > soy flour > soy isolate > 
soy concentrate. Soy concentrates, which are produced mostly via aqueous alcohol 
extraction are practically devoid of isoflavones because isoflavones are soluble in 
alcohol and are thus removed from soy concentrates (Anderson and Wolf, 1995). If a 
particular processing technique utililizes sufficient heat, conversion from the 
acetylisoflavones to the malonylisoflavones occurs (Wang and Murphy, 1994). The 
functional significance of this conversion relative to efficiency of absorption or 
biological activity in mammals is unknown. 
Of the three isoflavones found in soybeans, genistein is usually present in the highest 
amount (40-55%) with daidzein (30-40%) and glycitein (4-14%) present in lower 
amounts (Wang and Murphy, 1994). 
Absorption and Metabolism 
Isoflavones occur in soybeans predominantly (greater than 95%) in esterified 
forms (Wang and Murphy, 1994). Although the mechanism of absorption has not 
been delineated, cleavage of glucose moieties in the stomach via acid hydrolysis or in 
the small intestine via beta-glucosidase enzymes of bacteria is thought to be necessary 
31 
for absorption of the aglycone form to occur (Lu et al., 1995). Upon infusion via 
indwelling duodenal catheters in rats, 4-'"*C-genistein is rapidly absorbed, taken up by 
the liver and excreted into the bile as its 7-0-P-glucuronide conjugate (Sfakianos et 
al., 1997). However, genistein's appearance in the blood of rats is more rapid, and the 
initial concentrations are greater when oral administration is of the the aglycone 
genistein versus its esterified form genistin (King et al., 1996) suggesting hydrolysis 
of the esterified form is necessary prior to absorption. In addition, infusion of 
radioactive genistein into the duodenum of rats results in more rapid appearance of 
radioactivity in bile than when genistin is infused. 
Although the circulating form of genistein has been established as the 7-0-P-
glucuronideconjugate (Lundh et al., 1988; Sfakianoset al., 1997), the site of 
isoflavone glucuronidation is controversial. Most reports assume glucuronidation 
occurs in the liver simply because the liver has that capability. Indeed when 4-'"'C-
genistein is infused into the portal vein of rats, the glucuronidated form appeared 
quickly in bile suggesting hepatic glucuronidation. But when 4-''^C-genistein was 
infused into the duodenum, portal blood contained mostly glucuronidated genistein 
confirming that glucuronidation also occurs in the intestine (Sfakianoset al., 1997). 
In support of this, infusion of bile containing normal estrogens into the duodenum of 
gilts results in 17 beta-estradiol-glucuronide appearance in the hepatic portal vein 
(Ruoff and Dziuk, 1994). Intestinal glucuronidation has been confirmed using 
intestinal sac preparations in vitro (Lundh, 1990; Sfakianoset al., 1997). 
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Because genistein is subject to enterohepatic circulation as described above, 
urinary excretion of genistein is likely not a good measure of absorption. But urinary-
excretion levels may be useful for studying changes in relative absorption patterns 
over time. Healthy male subjects consuming a constant amount of daidzein and 
genistein daily for one month excreted 47% of ingested daidzein and 15% of ingested 
genistein in urine (Lu et al., 1995) and urinary recoveries did not change over time 
suggesting little bacterial adaptation to the isoflavones. However, the absorption 
half-lives and excretion half-lives for daidzein increased with prolonged soy 
exposure. Genistein's absorption half-life decreased but its excretion half-life 
increased suggesting prolonged isoflavone exposure may increase tissue exposure 
time (Lu et al., 1995). The absorption of daidzein and genistein in women over time 
appears to decrease with prolonged soy exposiire (Lu et al., 1996) and the absorption 
and excretion half-lives also decrease over time. Xu et al. (1995) suggested that 
humans who are high excreters of isoflavones also have high serum isoflavone 
concentrations implying that less bacterial degredation is related to greater 
absorption. Based on these data, adaptation to prolonged isoflavone exposure is 
dependent on gender, at least in humans. 
Daidzein has been suggested to be more bioavailable than genistein based on 
urinary excretion levels in women consuming isoflavones (Xu et al., 1994). But 
plasma concentrations of genistein and daidzein were approximately equal. But 
others have demonstrated that bioavailabilities of daidzein and genistein do not differ 
(Watanabe et al., 1998). Further complicating relative bioavailabilities of genistein 
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and daidzein is the fact that while genistein's enterohepatic circulation has been 
characterized, daidzein's has not. But it has been suggested that estrogenic 
compounds which are glucuronidated undergo enterohepatic circulation (Kurzer and 
Xu, 1997). Equal plasma concentrations of daidzein and genistein with lower urinary 
excretion of genistein suggests the extent of biliary excretion of daidzein is less than 
that of genistein. Furthermore, reports of genistein's enterohepatic circulation suggest 
that bioavailabilities carmot be estimated based exclusively on urinary excretion 
levels. 
Other factors may contribute to bioavailabilites of isoflavones such as dietary fiber 
level. Women consuming a high fiber diet excrete less genistein in urine and have 
lower plasma genistein levels than women consuming a low fiber diet (Tew et al., 
1996). The mechanism of this effect is not clear but could be related to the bulking 
effect and hydrophobic binding of fiber to genistein. Alternatively, adaptation of 
intestinal bacteria to a high fiber diet may favor bacteria that preferentially degrade 
isoflavones and produce metabolites such as equol (Lampe et al., 1998). 
Identification of human (Winter et al., 1989) and rat- (Griffiths and Smith, 1972) 
derived bacteria that are capable of metabolizing flavonoids has been documented. In 
addition, the origin of flavonoid metabolites has been demonstrated through the use 
of germ-firee rats (Griffiths and Barrow, 1972). The appearance of flavonoid fing-
fission products in urine of normal rats and their absence in the urine of germ-fi-ee 
rats indicates intestinal bacteria are responsible for metabolite production. Upon 
incubation with human bacteria, daidzein is transformed to dihydrodaidzein, O-
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desmethylangoensin, and equol. Gensitein is metabolized to dihydrogenistein which 
is further metabolized to 6'-hydroxy-0-DMA (Chang and Nair, 1995; Joaimou et al., 
1995; Setchell and Adlercreutz, 1988). Very few bacteria screened produce 
transformation products of isoflavones, but many screened bacteria produce 
transformation products of flavonoids (Ibrahim and Abdul-Hajj, 1990). 
Biological Effects: Estrogenic Properties 
Isoflavones are conmionly referred to as phytoestrogens because of their 
estrogenic properties (Reinli and Block, 1996b). Depending on the bioassay used, 
potencies of genistein relative to estradiol range from 0.1% (Markiewicz et al., 1993) 
to .001% (Reinli and Block, 1996a) with daidzein having slightly lower potencies. 
Isoflavones can also act as antiestrogens depending on the endogenous estrogenic 
state of an animal model (Herman et al., 1995). For example, phytoestrogens may be 
antiestrogenic in premenopausal women who already have a relatively high 
circulating level of estrogen. In post-menopausal women or ovariectomized animal 
models, lower levels of endogenous estrogen exist, and phytoestrogens are more 
likely to exert estrogenic effects. Thus the phytoestrogenic potency of isoflavones is 
dependent on the endogenous level of estrogen already present. Specific tissue 
responses to phytoestrogens include prevention of bone loss in ovariectomized rats 
(Aijmandi et al., 1996), increases in teat length and circumference in ovariectomized 
ewes (Nwannenna et al., 1995), infertility in normal ewes consuming phytoestrogens 
continuously during adult life (Adams, 1995), and increases in uterine weight of 
ovariectomized i-ats (Santell et al., 1997). In addition to immediate effects on adult 
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animals, phytoestrogens can have pennanent effects on developing animals afler 
withdrawal of phytoestrogens from the diet. Female rats whose dams were 
administered phytoestrogens during gestation had delayed puberty onset and atypical 
vaginal cycles (Levy et al., 1995). Rat pups exposed to phytoestrogens through the 
dam's milk were acyclic during early adulthood (Whitten et al., 1995). Neonatal rats 
exposed to phytoestrogens had lower uterine weights at puberty and a severe 
suppression of estrogen receptor levels (Medlock et al., 1995). Lutenizing hormone 
release in adult female and castrate males rats was increased in response to neonatal 
phytoestrogens (Register et al., 1995). Based on these data, phytoestrogens have 
pronounced effects on reproductive tract tissues and horaiones with subsequent long-
term effects after exposure to phytoestrogens has ceased. 
Immunomodulatory and Antioxidant The phytoestrogens daidzein and 
particularly genistein also have many other biological properties separate from their 
estrogenic properties. Daidzein, when fed to mice, increased thymus weight, 
stimulated the phagocytic rate of peritoneal macrophages, increased the degree of 
spleen cell-mediated sheep red blood cell hemolysis, and increased the proportion of 
peripheral blood T lymphocytes (Zhang et al., 1997). In vitro, daidzein increased 
levels of interleukins 2 and 3 in splenocyte cultures while genistein had the opposite 
effect (Wang et al., 1997). Daidzein and genistein both have antioxidant properties as 
shown by their ability to inhibit oxygen radical production by xanthine/xanthine 
oxidase. Genistein may also have indirect antioxidant effects by altering the activity 
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of the antioxidant enzymes catalase, superoxide dismutase, glutathione peroxidase 
and glutathione reductase (Wei et al., 1995). 
Tyrosine Kinase Inhibition Genistein has been shown to inhibit the activity of 
tyrosine kinase enzymes via competitive inhibition with the binding site for ATP 
(Akiyama et al., 1987). Tyrosine kinases are critical for transmembrane signal 
transduction because many polypeptide ligands (i.e. growth factors, cytokines) bind 
to membrane receptors which use intrinsic tyrosine kinase activity for signal 
transduction (Klohs et al., 1997; Showalter and Kraker, 1997). Ligands which rely on 
receptor tyrosine kinase activity for signal transduction include: platelet-derived 
growth factor, fibroblast growth factor, epidermal growth factor, insulin-like growth 
factor (IGF) and insulin (van der Geer et al., 1994). Polypeptide growth factors alter 
proliferation, differentiation, protein accumulation and survival in a wide variety of 
cell types (Fantl et al., 1993; van der Geeret al., 1994). Genistein inhibits IGF-I-
induced cell proliferation and hyaluronic acid synthesis in cultured thyroid cells 
(Takano et al., 1993) and mesothelial cells (Honda et al., 1991), respectively. 
Genistein also inhibits, EGF-induced growth of NIH-3T3 fibroblasts (Linassier et al., 
1990) and mouse lOTl/2 fibroblasts (Dean et al., 1989), EGF-induced hyaluronic 
acid synthesis in mesothelial cells (Hondaet al., 1991), and prolactin-induced growth 
of lymphoma cells (Buckley et al., 1993; Carey and Liberti, 1993). Genistein also 
inhibits the stimulatory action of PDGF on mitogenesis in mouse lOTl/2 fibroblasts 
(Deanet al., 1989), mouse osteoblast-like cells (Davidai et al., 1992), and rat aortic 
smooth muscle cells (Shimodado et al., 1995). Based on these data, genistein inhibits 
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the signaling action of a wide variety of growth factors in several different cell types. 
Genistein also has been shown to inhibit growth of cultured cells in mitogenic 
environments consisting of several growth factors or serum. Specifically, genistein 
inhibited proliferation and DNA synthesis in human trophoblasts (Hamlin and Soares, 
1995) and rat myoblasts (Hashimoto et al., 1995; Ji et al., 1997). Regardless of the 
mitogenic environment, the mechanism of genistein's inhibition could be at the level 
of the intrinsic tyrosine kinase activity of the membrane-bound receptor, or it could 
be down stream and thus, independent fi*om the receptor. Inhibition of both events 
also is possible. Cardiac muscle cell hypertrophy in response to alpha-adrenergic 
agonists was blocked by genistein (Thorbum and Thorbum, 1994) and the mechanism 
was shown to be inhibition of the Ras-MAP kinase signaling pathway which is 
downstream from growth factor receptors. The signaling pathway for insulin in rat 
adipocytes was shown to be inhibited independently from the tyrosine kinase activity 
of the receptor itself (Abler et al., 1992) suggesting a postreceptor signaling event 
was inhibited. In T cells, genistein inhibited phosphorylation of the T cell receptor 
and p56''^'', a protein tyrosine kinase which is separate from, but acts on, the T cell 
receptor (Trevillyan et al., 1990). 
Chemotherapeutic About half of the known oncogenes encode mutated forms of 
normal cellular proteins involved in growth factor-stimulated signal transduction 
(Hunter and Cooper, 1983). Genistein has been shown to inhibit cancer growth in 
several models, both in vitro and in vivo (Barnes, 1995). However, the effect of 
genistein on the growth of certain tiraior cells (human breast cancer) is concentration-
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dependent. At low concentrations (100-200 nM), and in the absence of estrogenic 
steroids, genistein stimulated growth of cultured human breast cancer cells. 
However, at concentrations greater than lyiM., genistein inhibited growth of breast 
cancer cells (Martin et al., 1978; Zava and Duwe, 1997). Based on these data, 
genistein's effects can be biphasic and may reflect estrogenic activities stimulating 
the estrogen receptor at low concentrations while inhibiting tyrosine kinase activity, 
and therefore cell growth, at higher concentrations (Barnes and Peterson, 1995). 
Glucose Transport Genistein has been reported to be a natural inhibitor of the 
glucose transporters GLUTl (Vera et al., 1996) and GLUT4 (Smith et al., 1993). 
Genistein's ability to block glucose transport was demonstrated to be via competitive 
inhibition of the glucose transporter and was thus independent of its ability to inhibit 
tyrosine activity. Thus the direct mechanism of genistein's ability to inhibit cell 
growth could be via interference with tyrosine kinase activity of membrane receptors, 
second messengers or both. Alternatively, genistein could simply be limiting glucose 
availability to cells and thus limiting growth. The Ki for inhibition of glucose 
transport was 7 p,M in intact cells whereas the Ki for inhibition of individual tyrosine 
kinases has not been determined. However, in T cells, the ID50 value for inhibition of 
the purified intracellular tyrosine kinase, p56''^'', was 40 j^M (Trevillyan et al., 1990). 
IC50 values for inhibition of tumor cell growth range from 2.6 to 79 |iM (Barnes, 
1995). Based on these data, the mechanism of growth inhibition by genistein is likely 
a combination of reduced glucose aveiilability to cells and reduced signaling via 
tyrosine kinases. 
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Saponins 
Saponins are high molecular weight glycosides consisting of a sugar moiety linked 
to a triterpene or steroid aglycone, referred to as the genin or sapogenin. Saponins are 
widely distributed in the plant kingdom and greater than 75% of plant species in some 
areas of the world contain saponins. Soybeans contain mainly triterpene saponins 
which have been reported to have many biological properties (Hostettmarm and 
Marston, 1995). Lists of antinutritional factors in soybeans have traditionally 
included saponins with little or no justification. Toxicity was attributed to them 
because saponins fi-om other sources are toxic (Cheeke and Shull, 1985). However, 
earlier studies (Ishaaya et al., 1986) showed that feeding soybean-derived saponins to 
chicks, rats, and mice at levels three to five times normally found in a soy-based diet 
failed to produce growth inhibition. Soyasaponin failed to alter zinc and iron 
absorption in rats whereas saponins firom other plant sources inhibited mineral uptake 
(Southon et al., 1988). Furthermore, anticarcinogenic, hypocholesteremic, 
antibacterial, antiviral, fungicidal, antiinflammatory, antiulcer, immunomodulatory, 
and analgesic activities of triterpene saponins have been documented (Messina and 
Barnes, 1991; reviewed by Hostettmann and Marston, 1995). Based on these data, 
soybean saponins are not toxic to meat animals and could be beneficial. However, 
their effects appear to be negligible (Ishaaya, et al., 1986). 
Summary 
Isoflavones are polyphenolic compounds which occur at high concentrations in 
soybeans. Soy products are a major component of food animal diets, and thus. 
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isoflavone consumption by food animals is high. Isoflavones have a plethora of 
biological activities including estrogenic, antioxidant, antimyogenic, and 
immunomodulatory effects. Many of these properties appear to be beneficial for 
human health. Based on these same properties, however, we hypothesize that the 
isoflavone genistein would be detrimental for animal growth. In vitro studies have 
shown that key myogenic events are inhibited by genistein. We have estimated, 
based on the range of genistein concentrations in soybeans, that young pigs 
consuming a soy-based diet may consume as much as 60 mg genistein "'kg BW'day 
which is likely to result in serum genistein concentrations three to five fold greater 
than would be required to inhibit myogenic events. Moreover, genistein and daidzein 
have opposing effects on biological events which may indirectly affect muscle 
growth. The impact of soy isoflavones on food animal growth and muscle content 
has not been quantified. Tlie objectives of studies in this dissertation were to 
determine the effect of soy isoflavones on growth and muscle content of animals 
receiving isoflavones during either prenatal or postnatal growth. 
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CHAPTER 3. THE EFFECT OF DIETARY SOYBEAN ISOFLAVONES ON 
CARCASS MUSCLE CONTENT AND BODY GROWTH IN PIGS FED FROM 
6 TO 30 KG BW 
A paper to be submitted to the Journal of Animal Science 
D.R. Cook" and T.S. Stahly^'^ 
Iowa State University, Ames, Iowa 
Abstract 
Fifteen pairs of littermate gilts were used to eveduate the effect of dietary soybean 
isoflavones on carcass muscle content and body growth rate. Within a litter, pigs were 
allotted to a basal diet supplemented with 0 or 1585 mg isoflavones/kg supplied by an 
extract of soybeans. The extract contributed 670 mg genistein. 705 mg daidzein and 
210 mg glycitein/kg diet, primarily in glycosidic forms, equivalent to 410, 420 and 
133 mg, respectively, of the free forms. Pigs were from a high lean genetic strain, 
weaned at 8 to 12 days of age. reared via SEW procedures and self-fed a milk-based 
diet until initiation of the study. The basal diet (1.8% lysine) consisted of a com. soy 
protein concentrate, lactose, crystalline amino acids and vitamin-mineral mix 
formulated to exceed nutrient needs of high lean pigs experiencing minimal antigen 
exposure. Isoflavones were added at the expense of com starch. Pigs were 
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penned individually and given ad libitum access to water and diets. Pig weights and 
feed consumption were recorded every 4 days and pigs were slaughtered at 30.7 ± 1.2 
kg BW. Isoflavones increased daily BW gain (579 vs 595 g, P < .06) but did not 
affect daily feed intake (911 vs 912 g, P > .1) nor gainifeed (.639 vs .656 g/g, P > .1). 
Isoflavones increased percentage carcass muscle (59.1 vs 60.1, P < .07) and estimated 
muscle gain/day (234 vs 245 g, P < .01), but did not affect percentage carcass fat 
(14.1 vs 13.3, P >.1) or carcass percentages of bone and skin nor visceral organ 
weights. Isoflavones increased the weight of predominantly red-fibered muscles 
(triceps brachii, rectus femoris, infraspinatus and psoas major) but not the weight of 
predominantly white-fibered muscles (vastus lateralis, semimembranosus, gluteus 
medius and longissimus dorsi). Based on these data, dietary isoflavones increased 
body growth rate, carcass muscle content, and growth of red-fibered muscles. 
Introduction 
Isoflavones are polyphenolic compounds found in soybeans (Reinli and Block, 
1996) at concentrations ranging from 100 to 5000 ppm depending on growing 
location, season and soybean variety (Kudou et al., 1991; Barnes et al., 1994; Wang 
and Murphy, 1994b; Ding et al., 1995). When consumed by mammals, isoflavones 
are absorbed and subsequently can be quantitated in blood and urine (Xu et al., 1994; 
Xu et al., 1995; King et al., 1996). Because soybean processing to produce soybean 
meal does not remove isoflavones, and pig diets may contain as much as 40 % 
soybean meal, the potential effects of isoflavones on pig growth are important. 
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The biological activities of isoflavones are numerous and include estrogenic 
properties (Medlock et al., 1995; Santell et al., 1997; Zava and Duwe, 1997), 
antioxidant effects (Esaki et al., 1994; Wei et al., 1995; Hodgson et al., 1996), 
inhibition of tyrosine kinase activity (Akiyama et al., 1987), immimomodulation 
(Trevillyan et al., 1990; Wang et al., 1997; Zhang et al., 1997), inhibition of DNA 
synthesis in placental trophoblasts (Hamlin and Soares, 1995), and suppression of 
myoblast proliferation and differentiation, which are critical processes for postnatal 
muscle growth (Hashimoto et al., 1995; Ji et al., 1997). Thus isoflavones have the 
potential to impact a wide variety of biological processes. Although numerous effects 
of individual isoflavones in vitro have been documented, the impact of of soy 
isoflavones on pig growth has not been quantified. Therefore, the objective of this 
study was to determine the effect of feeding supplemental soybean isoflavones to pigs 
from 6 to 30 kg BW on the animals' rate and efficiency of growth and carcass muscle 
content. 
Materials and Methods 
Pigs were fed a basal diet supplemented with 0 or 1585 ppm soy isoflavones from 
6 to 30 kg BW. The basal diet (17 ppm isoflavones) consisted of a com, lactose, and 
soy protein concentrate (produced via aqueous ethanol extraction) mix fortified with 
minerals and vitamins (Table 1). Diets were formulated to meet or exceed nutrient 
recommendations of high lean pigs experiencing minimal antigen exposure. The 
supplemental isoflavones were supplied by a soy extract, which was produced in a 
pilot extraction facility at Archer Daniels Midland Co., and analyzed 31.8 % 
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isoflavones (glycosidic and aglycone forms in Table 2) with the remainder consisting 
of saponins (Personal commimication, Eric Gugger, Archer Daniels Midland Co., 
Decatur, EL). The isoflavones consisted of glycosidic and aglycone forms of daidzein 
(13.4%), genistein (14.0%), and glycitein (4.4%). 
Fifteen pairs of littermate gilts with a high capacity for lean growth (370 g/d) were 
derived via a segregated early weaning scheme previously described (Stahly et al., 
1997) and randomly allotted within litter to the basal diet supplemented with either 0 
or 1585 ppm soy isoflavones. Pigs were penned individually on slatted floors in .61 x 
1.22 m pens from weaning until 18 kg BW, and in .61 x 2.44 m pens from 18 kg BW 
until 30.7 kg BW. Throughout the trial, pigs were housed in a temperature-
controlled, mechanically-ventilated building and had ad libitum access to water. Pigs 
were given ad libitum access to a commerical milk pellet diet for 7 d postweaning, 
then to experimental diets from 6.1 to 30.7 kg BW . 
Pig BW and feed consumption (corrected for feed wastage) were recorded every 4 
d. At 6.1 and 30.7 kg BW, pigs were bled via the orbital sinus. Blood was allowed to 
clot overnight at 4 ° C and then, serum was harvested via centrifugation, and stored at 
-20 ° C until analyzed for alpha-1 acid glycoprotein (AGP) concentrations. AGP was 
determined via radial immuno-diffusion assay kit (Developmental Technologies, 
Frederick, MD). 
As pigs reached a BW of 30 ± 1.5 kg they were given a lethal dose of sodium 
pentabarbitol and immediately exsanguinated. The right triceps brachii, vastus 
lateralis, rectus femoris, and semimembranosus muscles were immediately excised. 
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trimmed free of visible fat. and weighed to the nearest g. Carcasses were eviscerated 
and the offal components of heart-lungs, liver, kidneys, gastrointestinal tract (with 
digesta), and head were isolated and weighed to the nearest g. The right and left 
carcass sides and offal components were then stored at -20 ° C for subsequent 
analysis. The right carcass side was thawed at 5 ° C for 72 h and then physical 
diessected into muscle, fat, skin, and bone. During dissection, the longissimus dorsi. 
gluteus medius, infraspinatus, and psoas major muscles were excised intact, trimmed 
free of visible fat, and weighed to the nearest g. Each individual muscle isolated was 
classfied according to its fiber type composition (Beecher et al., 1965; Kiessling et 
al., 1982; Ono et al., 1995). Muscles with a high percentage of type-I and type-IIA 
fibers were considered red muscles whereas muscles with a high percentage of type-
IIB fibers were considered white muscles. The frozen left carcass side and viscera 
were each cut into pieces on a band saw, ground through a whole body and then 
subsampled (Williams et al., 1997). Samples were stored at -20 ° C, then freeze-
dried, allowed to air equilabrate, and analyzed for Kjeldahl nitrogen, ether extractable 
lipid, and dry matter according to (AOAC, 1995) procedures. Dissected muscle 
tissue was prepared and analyzed via the same procedures as outline above. 
Carcass muscle and fat tissue accretion rates were estimated by subtracting 
estimated tissue weights at initiation of the trial (30 % and 5 % of BW for muscle and 
fat, respectively (Williams et al., 1997) from their dissected carcass tissue quantities 
and dividing by number of days on test. 
The soy extract and experimental diets were analyzed for isoflavone concentration 
courtesy of Pat Murphy, Iowa State University according to the methods of (Wang 
and Murphy, 1994a; Wang and Murphy, 1994b). 
Data were analyzed as a randomized complete block design with variance 
techniques using the GLM procedure of (SAS, 1997) with litter serving as the block 
and pig as the experimental unit. Carcass weight was used as a covariate in the 
analysis of carcass tissues and individual muscle weights. Daily BW gain, daily feed 
intake, and gain:feed ratios were analyzed at three stages of growth via a repeated 
measures model. 
Results 
Supplemental isoflavones did not affect (P > .1) daily feed intake (911 vs 911 g), 
or gainrfeed ratios (639 vs 656 g/kg) but increased (P < .06) daily BW gain from 579 
g to 595 g (Table 3). The concentration of the acute phase protein, alpha-1 acid 
glycoprotein was assayed in serum at the initiation and termination of the trial and 
was not altered (P > .1) by isoflavone regimen (Table 3). A repeated measures 
analysis for daily BW gain, daily feed intake, and gain:feed ratios also was used when 
pigs' BW averaged 10.0, 18.0, and 26.0 kg (Table 4). Using this analysis, no 
significant differences were detected (P > .1) in response to supplemental isoflavone 
regimen. 
Supplemental isoflavones increased (P < .07) die percentage of carcass muscle 
(Table 5) from 59.1 to 61.0 but did not (P > .1) affect carcass percentages of fat (14.1 
vs 13.3), bone (17.7 vs 17.1), and skin (9.0 vs 8.6). Estimated carcass muscle 
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accretion rate was increased (P < .02) by isoflavones (251 vs 266 g/d). Estimated fat 
accretion was not altered (P > .1) by isoflavones (63 vs 61 g/d). Although carcass 
muscle was increased by isoflavones, the chemically-determined percentages of 
protein (19.8 vs 20.5) and fat (14.0 vs 13.4) on the left carcass side (Table 5) were 
not statistically altered (P > .1) by feeding isoflavones. The chemical composition of 
dissected muscle did not differ (P > .1) between treatments. 
Eight individual muscles were dissected intact and trimmed free of external fat 
prior to carcass dissection (Table 6). The combined weight of four red muscles (psoas 
major, infraspinatus, triceps brachii, and rectus femoris) was increased (P < .01) by 
isoflavones (380 vs 409 g) but the combined weight of four white muscles 
(longissimus dorsi, semimembranosus, gluteus medius, vastus lateralis) was not altered 
(P > .1) by isoflavones (1153 vs 1142 g). Thus the muscle growth response to dietary 
isoflavones was dependent on muscle fiber type. 
Visceral component weights (Table 7) of head, liver, kidneys, heart/limgs, and 
gastrointestinal tract were not altered (P > .1) by isoflavones nor was chemical 
composition of the combined offal components (P > . 1). 
Discussion 
The isoflavone composition of soybeans grown in different locations and seasons 
varies widely with ranges of 56-71% genistein, 16-38% daidzein, and 4-13% 
glycitein by weight (Wang and Murphy, 1994b; Ding et al., 1995). The composition 
of supplemental isoflavones in the current study was similar to the isoflavone 
composition of soybeans, although the genistein concentratiosn was slightly lower 
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and daidzein slightly higher than soybeans. The total concentration of supplemental 
isoflavones used (1585 ppm) is equivalent to a diet containing 35% soybean meal, 
which in turn contains 4285 ppm isoflavones. The soy extract was reponed to be 
70% saponins which do have some biological activities (reviewed by Hostettmann 
and Marston, 1995). But soybean saponins failed to alter animal growth when fed at 
concentrations five time that found in soybeans (Ishaaya et al., 1986). Thus diet-
induced differences in in this study are discussed in the context of the biological 
activities of isoflavones. 
Although measures of isoflavone absorption were not undertaken in the present 
study, we quantified urinary recoveries of genistein and daidzein in gravid rats fed the 
same soy extract as was used in this study (Chapter 5, Table 5). Based on these data, 
both daidzein and genistein in the soy extract are bioavailable. Further studies at our 
station showed that both genistein and daidzein from a different dietary source were 
absorbed in a dose-dependent fashion based on serum concentrations in pigs (Chapter 
4, Table 6). Thus, we have established that isoflavones are bioavailable to pigs and 
that isoflavones from the source used in the current study also are bioavailable. 
Isoflavones are metabolized by intestinal microflora (Kurzer and Xu, 1997) and 
thus, estimates of daidzein's greater bioavailability relative to genistein have been 
based on percent urinary recoveries (Xu et al., 1994). But isoflavones also are 
subject to enterohepatic circulation (Sfakianos et al., 1997), biliary excretion, and 
subsequent metabolism. Thus, when serum levels of genistein and daidzein are 
considered relative to their dietary concentrations (Xu et al., 1994), bioavailabilities 
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of genistein and daidzein seem to be similar. Consequently, the biological activities 
of both genistein and daidzein must be considered in the context of altered pig growth 
and muscle content in this study. 
Daily BW gain and carcass muscle percentage were increased by dietary 
isoflavones in the current study suggesting that the negative effects of genistien 
observed in vitro on myoblast proliferation (Hashimotoet al., 1995; Jiet al., 1997) and 
glucose transport (Smith et al., 1993; Vera et al., 1996) did not impact pig growth in 
vivo at the isoflavone concentration tested. The increased muscle growth occurred 
predominantly in muscles classified as red. Recently, daidzein has been shown to 
increase secretion of the cytokine, interleukin-3 by cultured lymphocytes (Wang et 
al., 1997). Interleukin-3 has been shown to promote glucose transport in a myeloid 
cell line by regulating affinity of the glucose transporter for glucose (Berridge and 
Tan, 1995; McCoy et al., 1997). Muscles with a predominance of type-I fibers (red) 
possess greater concentrations of glucose transporters relative to muscles with a 
predominance of type-II (white) fibers (Goodyear et al., 1991). If muscle tissue also 
is responsive to interleukin-3, daidzein-induced interIeukin-3 production could 
increase glucose transport, and thus energy supply and growth, to a greater extent in 
red vs white muscles. The biological effects of interleukin-3 have not been 
characterized in pigs. 
Other cytokines, such as interleukin-1, and tumor necrosis factor alpha are 
classified as "proinflammatory" and have negative effects on muscle growth when 
produced in response to immune stimulation (Klasing, 1988; Williams et al., 1997). 
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Conversely, mimimizing chronic immune activation, and thus proinflammatory 
cytokine level, increases muscle growth. Daidzein increased production of the non-
proinflammatory cytokine, interleukin-2 in cultured lymphocytes, and when fed to 
mice, increased thymus weight and the proportion of peripheral blood T-lymphocytes 
(Zhang et al., 1997). Exogenous IL-2 has been shown to increase recovery rate from 
an intramammary bacterial challenge and to give greater protection against a viral 
challenge in mice (Daley et al., 1991; Schijns et al,, 1994). Thus, daidzein-induced 
IL-2 secretion could result in enhanced immune function, and thus more rapid 
elimination of pathogens resulting in less chronic immune activation and lower levels 
of pro-inflammatory cytokines. But serum concentrations of AGP, an acute-phase 
protein produced in response to proinflammatory cytokines, were not altered by 
isoflavones in this study suggesting that pro-inflammatory cytokine levels were not 
altered. 
Daidzein and genistein are referred to as "phytoestrogens" because of their 
estrogenic activity in several different experimental models (Medlock et al., 1995; 
Santellet al., 1997; Zava and Duwe, 1997). Estrogens influence the pituitary axis by 
stimulating growth hormone release (Tannenbaum et al., 1992; De Leo et al., 1993; 
Marin et al., 1994; Metzger and Kerrigan, 1994; Moe et al., 1998), growth hormone 
receptor expression and growth hormone action in bone cells (Slootweg et al., 1997), 
and IGF-I in tissue and serum (Murphy et al., 1987; Norstedt et al., 1989; Pollak et 
al., 1990; Pollak et al., 1992; Sahlin, 1995). Moreover, tyrosine kinase inhibitors, 
including genistein, enhance growth hormone releasing hormone-stimulated growth 
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hormone release in rat anterior pituitary cells (Ogiwara et al., 1997). However, 
administration of porcine somatotropin to pigs from 30 to 60 kg BW increases the 
cross sectional areas of all fiber types (Solomon et al., 1990; Solomon et al., 1991) 
whereas our data suggest a muscle growth response specific to red-fibered muscles. 
Based on our data, dietary isoflavones fed in similar proportions to isoflavones in 
soybeans, increased muscle growth in young pigs and this response was specific to 
muscles which have a high proportion of red fibers. Further, genistein's inhibitory 
effect on glucose transport and myoblast proliferation in vitro were not inhibitory to 
muscle growth in vivo. 
Implications 
Soybean isoflavones are naturally occurring substances which appear to be benficial for 
pig growth and muscle content. Elucidation of which isoflavone(s) elicits anabolic 
effects will allow identification the mechanims responsible for differential effects on red 
and white muscles which may have important implications for muscle growth and meat 
quality. Subsequently, soybeans and soybean products could be designed to contain 
optimal isoflavone levels for muscle growth and meat quality in pigs. Development of 
technologies to economically manipulate dietary isoflavone levels will be crucial to 
allow the benefits of isoflavones on growth to be realized. 
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Table 1. Basal diet composition, 
Item Amount, % 
Com 37.59 
Soy protein concentrate 38.28 
Lactose 15.00 
Com oil 2.00 
Com Starch .50 
Soy extract*^ — 
Mono-dicalcium phosphate 3.90 
Limestone .41 
Salt .40 
Crystalline amino acids 1.02 
Trace mineral-vitamin mix^ .90 
Basal diet contained 17ppm isoflavones. 
"Provided the following per kg of diet: Biotin, .30 mg; choline, 1800 mg; folic acid, 
1.80 mg; niacin, 90.0 mg; riboflavin, 21.0 mg; pantothenic acid, 60.0 mg; pyridoxine, 
9.0 mg; thiamine, 6.0 mg; Vit E, 96 lU; Vit A, 13,200 lU; Vit D3, 1323 lU; 
menadione, 3.0 mg; Vit B12, .105 mg; Cu, 17.5 mg; Fe, 175 mg; Mn, 60 mg; Se, .30 
mg; Zn, 226 mg; 
"^Isoflavone composition of soy extract described in table 2. 
74 
Table 2. Isoflavone composition of soy extract. 
Isoflavone content, mg/g® 
Isoflavone form Total Normalized 
Glycosidic forms 
Daidzin 107.83 68.32 
6"-0-Acetyldaidzin 16.40 9.41 
6"-0-Malonyldaidzin 15.55 8.11 
Genistin 105.91 68.60 
6"-0-acetylgenistin 14.93 8.78 
6"-0-Malonylgenistin 12.37 6.64 
Glycitin 33.93 23.62 
6"-0-acetyIglycitin 1.96 1.24 
6"-0-Malonylglycitin 5.03 2.92 
Total glycosidic forms 313.91 197.64 
Aglycone forms 
Daidzein 1.41 1.41 
Genistein 1.13 1.13 
Glycitein 1.07 1.07 
Total aglycone forms 3.61 3.61 
Total isoflavones 317.51 201.25 
Normalized amount = (molecular weight of aglycone form/molecular weight of 
glycosidic form)x mg of glycosidic form in soy extract. 
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Table 3. Effect of dietary soy isoflavones on pig growth and feed utilization and on 
serum alpha-1 acid glycoprotein (AGP) concentrations®. 
Item 
Supplemental isoflavones, ppm 
0 1585 cv,% Probability 
No. of pens 13 15 
Pig weight, kg 
Initial 6.17 6.18 2.6 .17 
Final 30.90 30.57 1.8 .71 
Pig growth and feed utilization'' 
Body gain, g/d 579 595 3.0 .06 
Feed intake, g/d 911 911 5.9 .98 
Gain; feed, g/kg 639 656 5.1 .26 
Serum AGP, p-g/ml 
Initial 754 750 21.8 .95 
Final 435 409 11.0 .48 
Pigs penned individually and self -fed a basal diet supplemented with 0 or 1585 ppm 
soy isoflavones. 
"^inal pig weight used as covariate for analysis of pig growth and feed utilization 
data. 
Table 4. Eflect of supplemental isoflavones on pig growth and feed utilization at three stages of growth. 
Item 
Stage of growth, Supplemental isoflavone, ppm 
CV, % 
Probability 
kg BW 0 1585 Isoflavone isoflavone x BW 
Body gain, g/d 6 to 14 444 454 10.8 .45 .88 
14 to 22 622 636 
22 to 30 701 718 
Feed intake, g/d 6 to 14 516 510 10.4 .71 .65 
14 to 22 1047 1087 
22 to 30 1295 1316 
Gain: feed, g/kg 6 to 14 865 892 6.4 .38 .43 
14 to 22 599 589 
22 to 30 545 552 
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Table 5. Effect of supplemental soy isoflavones on carcass tissue percentages, accretion 
rates, and chemical composition. 
Supplemental isoflavones, ppm 
Item 0 1585 CV,% Probability 
Carcass wt., kg 21.2 21.0 1.8 .15 
Carcass tissue, kg® 
Muscle 12.48 12.87 3.5 .08 
Fat 3.02 2.80 12.9 .21 
Bone 3.77 3.58 10.0 .27 
Skin 1.92 1.79 9.6 .11 
Carcass tissue gains, g/d® 
Muscle 234 248 5.0 .02 
Fat 53 50 12.8 .41 
Dissected muscle chemical content, % 
Protein 21.4 21.3 3.7 .62 
Fat 5.1 5.0 5.1 .22 
Carcass chemical content, % 
Protein 19.8 20.5 6.1 .26 
Fat 14.0 13.4 14.9 .53 
^Carcass weight used as a covariate. 
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Table 6. Effect of dietary soy isoflavones on weights of red and white-fibered muscles.^ 
Supplemental isoflavones, 
ppm 
Item 0 1585 CV,% Probability 
Red-fibered muscles, g 
Psoas major 100.1 107.4 12.6 .22 
Infraspinatus 51.3 59.6 14.3 .03 
Triceps brachii 102.0 107.9 6.6 .07 
Rectus femoris 126.5 133.9 3.0 .01 
Total 379.8 408.8 5.4 .01 
White-fibered muscles, g 
Longissimus dorsi 621.5 618.7 8.1 .90 
Gluteus medius 84.8 83.6 9.8 .75 
S emimembranosus 341.9 328.1 5.8 .14 
Vastus lateralis 104.5 112.0 7.6 .06 
Total 1152.6 1142.3 5.2 .70 
^Carcass weight used as a covariate. 
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Table 7. Effect of dietary soy isoflavones on offal component weights and chemical 
composition. 
Supplemental isoflavones, ppm 
Item 0 1585 CV,% Probability 
Offal component weights, kg 
Head 2.135 2.220 6.4 .19 
Liver .808 .779 6.6 .24 
Kidneys .154 .149 7.8 .36 
Heart-lungs .544 .529 15.0 .69 
Gastrointestinal tract 4.167 4.218 9.7 .78 
Total 7.808 7.895 8.0 .62 
Offal chemical composition, % 
Protein 13.9 14.1 7.6 .76 
Fat 7.0 6.8 10.7 .58 
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CHAPTER 4. THE EFFECT OF DIETARY GENISTEIN ON CARCASS 
MUSCLE CONTENT AND BODY GROWTH IN PIGS FED FROM 5 TO 28 
KGBW' 
A paper to be submitted to the Journal of Animal Science 
D.R. Cook\ R.C. Ewan\ and T.S. Stahly^'^ 
Iowa State University, Ames, Iowa. 
Abstract 
Twelve sets of five littermate barrows from a high lean genetic strain were used to 
evaluate the effect of dietary genistein on carcass muscle content and body growth 
rate of pigs fed from 5 to 28 kg. Within a litter, pigs were allotted to a basal diet 
supplemented with 0, 200, 400, 600 or 800 ppm genistein. Genistein was supplied in 
the diet as a semi-purified soy extract at the expense of com starch. Pigs were 
weaned at 8 to 12 days of age, reared via SEW procedures and self-fed a milk-based 
diet until initiation of the study. Serum concentrations of genistein increased linearly 
(p< .01) as dietary genistein increased. However, dietary genistein did not alter (P > 
.10) daily BW gain (566, 561, 555, 551, 566 g), daily feed intake (689, 681, 704, 679, 
677 g) nor gain:feed ratios (821, 826, 793, 815, 840 g/kg). Dietary genistein also did 
not alter (P > .1) the combined weight of four muscles with a predominance of red 
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grateful for the assistance of Brian Kremer, Richard Clayton, and Jeff Kurt in the 
collection of the data. 
"Present address, Akey, Inc., 250 W. Clay St., Lewisburg, OH 54338. 
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fibers nor four muscles with a predominance of white fibers. The weights of head, 
liver, kidneys, and GI tract were not altered (P > .1) by dietary genistein. Heart/lung 
weights decreased linearly (P < .04) with increasing dietary genistein (681, 666, 619, 
608, 619 g). These data indicate that while dietary genistein is absorbed in a dose-
dependent fashion, dietary concentrations up to 880 ppm do not alter the rate and 
efficiency of growth nor the carcass muscle content of pigs fed firom 4.5 to 28 kg BW. 
Introduction 
Isoflavones are polyphenolic bioavaiblable compounds that are present in 
soybeans at concentrations up to 5000 ppm (Kudou et al., 1991; Wang and Murphy, 
1994a; Wang and Murphy, 1994b). Because soybean processing to produce soybean 
meal does not remove isoflavones, and pig diets may contain as much as 40 % 
soybean meal, the potential effects of isoflavones on pig growth may be important. In 
a previous study at our station (Chapter 3), we showed that dietary inclusion of 1585 
ppm isoflavones, obtained fi-om a soy extract increased growth rates and carcass 
muscle percentage in young pigs. The bioactivity of individual isoflavones, genistein, 
daidzein, and glycetein are not known. However, based on in vitro data, genistein 
could be detrimental to muscle growth because it suppresses myoblast proliferation, 
protein synthesis, differentiation, and expression of the myogenic regulatory factor 
gene myogenin (Hashimoto et al., 1995; Ji et al., 1997) which are critical processes 
for muscle growth. The concentration of genistein required to inhibit myoblast 
proliferation in vitro is reported to be as low as 1.0 |iM (Ji et al., 1997). In rats, peak 
and prolonged (12 h) serum concentrations of 12 and 4.5 jiM, respectively, have been 
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been achieved with an oral bolus dose of 20 mg.'^kg BW of the aglycone form of 
genistein. Prolonged (12 hours) serum concentrations of 4.5 jiM also were achieved 
with the conjugated form of genistein (King et al., 1996). Based on concentrations of 
dietary isoflavones reported in the literature (Wang and Murphy, 1994a; Wang and 
Murphy, 1994b), young pigs consuming soy-based diets commonly consume 
quantities of genistein in excess of 20 mg.''kg BW."'d. Therefore, we wanted to 
determine whether genistein would have on negative effect on muscle growth in the 
absence (low concentrations) of other isoflavones. This study was conducted to 
determine the effect of feeding supplemental soybean genistein to pigs from 4.5 to 
27.7 kg BW on their rate and efficiency of growth and carcass muscle content. 
Materials and Methods 
Twelve sets of five littermate barrows with a high capacity for lean growth (370 g/d) 
were randomly allotted within litter to a basal diet (Table 1) supplemented with 0. 
200, 400, 600 or 800 ppm supplemental genistein. The basal diet contained com, 
dried whey, and soy protein concentrate produced via aqueous ethanol extraction, and 
was formulated to to meet or exceed nutrient needs of high lean growth pigs (Table 
1). The supplemental genistein was supplied by a soy extract containing 72% 
genistein, 9% daidzein, and 1% glycitein, primarily in the glycosidic form (Table 2). 
The extract was purchased from Wiley Organics, Coshocton, OH. Normalized to the 
aglycone form, the extract contained 46.6% genistein, 5.5% daidzein, and .8% 
glycitein. (Table 2). The genistein source was added to the basal diet at the expense 
of com starch. 
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Pigs were derived via a segregated early weaning scheme as previously described 
(Stahly et al., 1997). Pigs were penned individually in .61 x 1.22 m pens on slatted 
flooring in a temperature-controlled enviroiraient (31.1 ° C on d 0, reduced 
temperature .8 ° C every 8 d) and had ad libitum access to feed and water. Pigs were 
fed a commercial milk pellet diet for seven d postweaning, then placed on their 
respective experimental diets. The milk pellet diet contained approximately 5% soy 
products and was not analyzed for isoflavone content. 
Pig BW, feeder weights, and feed wastage were recorded every 4 d. On d 8, 16, 
24, and 32 of the study, pigs were bled via the orbital sinus, blood was allowed to clot 
overnight at 4 ° C, and serum was harvested via centrifiigation, and stored at -20 ° C 
until analyzed. Serum alpha-1 acid glycoprotein (AGP) concentrations were 
determined via a radial immunodiffusion assay kit (Developmental Technologies, 
Frederick, MD), and serum genistein concentrations were determined via HPLC with 
spectrophotometric detection. 
At a BW of 30.7 ± 1.5 kg pigs were penned individually and transported 8 km to 
the Iowa State University Meat Laboratory where they were electrically stimned and 
killed by exsanguination. Immediately following exsanguination, the right triceps 
brachii, vastus lateralis, rectus femoris, and semimembranosus muscles were excised, 
trimmed free of visible fat, and weighed to the nearest g. The remainder of the right 
carcass side was stored at -20 C. The right side was then thawed at 4 C for 72 h, and 
four additional individual muscles consisting of the longissimus dorsi, gluteus 
medius, supraspinatus, and psoas major were excised intact, trimmed free of visible 
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fat, and weighed. Muscles were classified as red or white based on their reported 
fiber type composition (Beecher et al., 1965; iCiessling et al., 1982; Ono et al., 1995). 
Muscles with a high percentage of type-I and type-IIA were classified as red and 
muscles with a high percentage of type-IIB fibers were classified as white. Carcasses 
were eviscerated and the offal components of heart-lungs, liver, kidneys, 
gastrointestinal tract (with digesta) were weighed. 
The genistein extract and experimental diets were analyzed for isoflavone 
concentration courtesy of Pat Murphy, Iowa State University according to the method 
of (Wang and Murphy, 1994a; Wang and Murphy, 1994b). 
Serum isoflavone concentrations were analyzed using modifications of King et al. 
(1996) and Franke et al. (1995). Sera were thawed, gently vortexed, and l.O ml was 
placed in a 13 X 100 mm borosilicate glass tube (Fisher Scientific). One ml of buffer 
(.17 M ammonium acetate, pH 4.6 containing 1.67 ml Beta-glucuronidase/lOOml) 
was mixed thoroughly with the serum and the tubes were covered with parafibn and 
incubated a minimum of eight hours at 37 ° C. The serum-ammonium acetate mixture 
was then extracted twice by adding 2.0 ml of diethyl ether to each tube, vortexing 
gently, centrifiiging at 1000 x g for 15 min, and transferring the ether to another tube. 
Combined ether extracts were then evaporated under a stream of nitrogen and dried 
residue was dissolved in 200 |al of 80% aqueous methanol. Fifty ^1 was injected for 
liquid chromatographic quantification. 
The HPLC conditions were as follows: The column was a 3.9 x 300 mm C'^ 
Bondapak with a pore size of 10 p.m. Mobile phase A consisted of HPLC grade 
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methanol and mobile phase B consisted of. 1 M ammonium acetate, pH 4.6 and 25 
mM EDTA in a 50:1 ratio. Gradient elution was utilized in the following manner: 
42.5% to 52% mobile phase A in B from injection to 17.1 minutes, then 60% A to 25 
minutes and 42.5% A in B to 30 minutes at a flow rate of 1.0 ml/min. In this system, 
daidzein eluted at approximately 15.1 min and genistein eluted at approximately 21.0 
min. Dual beam spectrophotometric detection was used at a wavelength of 260 nm 
and an AFU setting of .02. Standards consisting of 1.5625, 3.125, 6.25, 12.5, 25, 50 
and 100 jiM daidzein and genistein in 80% aqueous methanol were used to calculate 
a standard curve using peak area. These procedures yielded recoveries of 81 and 84% 
for daidzein and genistein, respectively, with intra-assay CVs of 7.5 and 11%. 
Data were analyzed by variance techniques using the GLM procedure of (SAS, 
1997). The design was a randomized complete block with litter serving as the block 
and pig as the experimental unit. Linear, quadratic and cubic responses to 
supplemental genistein were determined. Carcass weight was used as a covariate in 
the analysis of individual muscle and carcass tissue weights. Daily BW gain, daily 
feed intake, gain:feed ratios, serum AGP, genistein, and daidzein concentrations 
measured at different stages of pig growth were analyzed via a repeated measures 
analysis. 
Results 
Genistein and daidzein were absorbed in a dose-dependent fashion as evidenced 
by serum genistein and daiidzein levels that increased linearly (P < .01) with 
increasing dietary genistein and daidzein levels (Table 3). Serum concentrations of 
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the acute phase protein, alpha-1 acid glycoprotein (AGP) increased quadratically (P 
< .05) in response to increasing dietary genistein (Table 3). Over the duration of the 
trial, supplemental genistein did not affect (P > .1) daily BW gain (566, 561, 555, 
551, 566 g,), daily feed intake (689, 681, 704, 679, 677 g) nor gain:feed ratios (821, 
826, 793, 815, 840 g/kg. Table 3). The combined weight of four red muscles (triceps 
brachii, rectus femoris, supraspinatus and psoas major) was not affected (P > .1) by 
dietary genistein (410, 404, 413, 408, 412 g; P . > 1) nor was the combined weight of 
four white muscles (vastus lateralis, semimembranosus, gluteus medius and 
longissimus dorsi; 1175, 1191, 1198, 1160, 1197 g; Table 4). The weights of head, 
liver, kidneys, and GI tract were not altered (P > .1) by dietary genistein (Table 5). 
Heart/lung weights decreased linearly (P < .04) with increasing dietary genistein 
(681.666,619, 608, 619 g;). 
Repeated measures analysis showed that genistein decreased BW gain from 4.5 to 
10.5 kg BW but increased BW gain during the following two stages of growth 
resulting in a genistein quadratic by BW quadratic interaction (P < .04). Daily feed 
intake responded similarly to BW gain but the genistein-induced increase in feed 
intake seemed to be maintained through the last phase of growth (genistein quadratic 
by BW linear, P < .01). Gain:feed ratios tended to be improved by genistein during 
the second stage of growth and decreased quadratically during the last stage of 
growth resulting in a genistein quadratic by BW quadratic interaction (P < 04; Table 
7). 
87 
The elevated serum concentrations of genistein and daidzein observed as dietary 
genistein increased were independent (P > .1) of the number of days on test (Table 6). 
However, the elevated concentrations of serum AGP in genistein-fed pigs diminished 
over time (genistein x day P < .04; Table 8). 
Discussion 
In a previous study with young pigs at our station (Chapter 3), feeding equal levels 
of daidzein and genistien from a soy extract from 6 to 30 kg BW increased muscle 
growth. Specifically, weights of red muscles increased in response to supplemental 
dietary isoflavones but white muscle weights were not altered. Isoflavones in the 
previous study were suppled by a soy extract that contained equal amounts of 
genistein and daidzein. By design, dietary genistein levels in the current study were 
much greater than daidzein levels and thus, biologic effects of genistein should have 
been predominant 
In vitro, genistein inhibits the critical muscle growth process of myoblast 
proliferation in a dose-dependent maimer at concentrations as low as 1.0 |j.M 
(Hashimoto et al., 1995; Ji et al., 1997). In the current study, serum genistein 
concentrations increased linearly in response to increasing dietary genistein with 
maximal concentrations of 3.5 i^M. However, overall daily BW gain and gainifeed 
ratios were not altered. Moreover, the weights of seven individual muscles, including 
the economically important muscles of longissimus dorsi, semimembranosus, and 
psoas major, did not change in response to dietary genistein. One muscle, the 
supraspinatus, responded quadratically to genistein, but, in view of its small size (20 
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g), the economical and biological significance of this change is negligible. Based on 
these data, serum concentrations of genistein 3.5-fold greater than are required to 
mhibit myoblast proliferation in vitro are not sufficient to inhibit muscle growth in 
vivo. 
As discussed in Chapter 3, daidzein has biologic properties that may positively 
influence muscle growth. Wang et al, (1997) reported that genistein and daidzein 
have opposing effects on production of the cytokine interleukin-3 which stimulates 
glucose transport in some cell types and might influence muscle growth (see Chapter 
3 for discussion). The concentration of daidzein (.01 ^M) required to stimulate 
interleukin-3 production was much lower than the concentration of genistein (1.0 
|j.M) required to inhibit IL-3 production. Opposing effects of these two isoflavones 
could eliminate in vivo responses. Moreover, daidzein has been reported to have a 
greater bioavailability than genistein based on urinary excretion levels which might 
suggest greater absorption and thus circulating concentrations of daidzein vs 
genistein. But circulating levels of genistein and daidzein in the same study (Xu et 
al., 1994) suggest similar bioavailabilities. In the current study, the genistein source 
contained 8-fold greater genistein concentrations relative to daidzein but circulating 
concentrations of genistein were only 3 to 4-fold greater than daidzein. Thus, the 
observed relationship between dietary concentrations of genistein and daidzein 
relative to circulating concentrations support greater bioavailability of daidzein vs 
genistein. 
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Another possible reason for genistein's lack of effect on muscle growth in vivo is 
that the metaboUsm of genistein in vivo may potentially influence its bioactivity 
relative to the aglycone form which is typically used in vitro. Sfakianos et al. (1997) 
administered the aglycone form of radioactive genistein via indwelling duodenal 
cannulas to rats and observed genistein-glucuronide shortly thereafter in the 
carmulated hepatic artery and later in bile. Lundh, (1990) showed that conjugation of 
daidzein occurs in intestinal tissue. Thus, the circulating form of both genistein and 
daidzein are conjugated. Conjugated forms of genistein have not been tested for their 
ability to inhibit myoblast proliferation or glucose transport in vitro. However, in 
light of the plethora of biological activities reported for isoflavones in vivo, it seems 
unlikely conjugation would completely eliminate genistein's effects on myoblast 
proliferation and glucose transport. Altematively, myoblast sensitivity to genistein 
may differ in vivo vs in vitro. 
Pigs fed supplemental genistein consumed less feed and gained BW slower during 
the initial phase of growth from 4.5 to 10.5 kg BW. However, this was reversed 
during later stages of growth. Isoflavones have a bitter flavor and may influence 
feed intake. In other studies performed at our station (unpublished observations), the 
more genistein present in diets for newly weaned pigs, the more difficult it was to get 
young pigs to begin consuming feed. Thus, palatability may influence how readily 
young pigs begin consuming diets containing isoflavones. Increased feed intake and 
body growth rate in response to genistein during later stages of growth may represent 
a compensatory response once pigs are accustomed to diets containing genistein. 
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Alternatively, genistein could impact physiogical cues for feed intake. In vitro, 
genistein inhibits glucose transport (Smith et al., 1993; Vera et al., 1996) which 
would decrease glucose disposal rate and thus decrease feed intake. But amelioration 
of this response is perplexing in the face of consistent serum genistein concentrations 
over a 24-d period. 
Serum concentrations of AGP were lowest in pigs receiving no supplemental 
genistein and increased quadratically in response to genistein. The response 
diminished with increasing days on test so that concentrations of AGP were similar 
between dietary genistein levels at the end of the study. Acute-phase proteins, such 
as AGP, are produced in the liver in response to pro-inflammatory cytokines such as 
interleukin-1 and interleukin-6. Concentrations of AGP are high in young pigs and 
decrease rapidly with increasing age (Williams et al., 1997). Immune challenge, 
which increases pro-inflammatory cytokine concentrations, increases AGP 
concentration, or at least slows their rate of decline. Therefore, our data which show 
increased AGP concentrations in response to genistein conflict with genistein's 
documented inhibitory effect on cytokine release and signaling in vitro (Trevillyan et 
al., 1990; Thompson et al., 1993). It is interesting to note that pigs in this smdy had a 
persistent cough that began within 5 d after initiation of the trial. Although no 
antibody titers were detected for the respiratory antigens Actinobacillus 
pleuropneumonia and Mycoplasma hyopneumonia at initiation and termination of the 
trial, lung tissue collected at slaughter had lesions consistent with mycoplasmal 
pneumonia. In addition, combined weights of heartAungs decreased linearly with 
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increasing dietary genistein. This could be representative of decreased 
immunoresponsiveness to a respiratory pathogen and thus decreased lung weights. 
Alternatively (Thorbum and Thorbum, 1994) reported that genistein inhibits cardiac 
muscle cell hypertrophy in vitro which could decrease heart muscle growth. Because 
heart and lungs were not separated in our study, both of these potential responses 
should be considered. 
Based on concentrations of genistein reported for common varieties of soybeans 
(Wang and Murphy, 1994b), young pigs consuming soy-based diets consume enough 
genistein to have circulating genistein concentrations of .5 to 5.0 (J.M. In our study, 
genistein was absorbed in a dose-dependent fashion throughout the trial, reached 
circulating concentrations as high as 3.5 |i.M, but did not inhibit muscle growth. The 
reasons for the lack of response on muscle growth in vivo relative to genistein's 
inhibitory effects on myoblast proliferation in vitro are not clear. Previous data from 
our station in which daidzein and genistein were fed at similar levels suggest a 
positive effect of isoflavones on muscle growth. Taken together, data from both 
studies seem to support a positive role for daidzein in muscle growth. This 
hypothesis has not been tested. Our data suggest that high isoflavone concentrations 
in soy-based diets may present palatability problems for very young pigs, but do not 
diminish the value of soy products as feed ingredients for pigs. 
Implications 
Based on these data, soy feed ingredients containing high levels of genistein are 
not detrimental for pig performance and muscle growth. Because of the benefits to 
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human health, and because genetic modification of grains is becoming more common, 
it is reasonable to suggest that soybean varieties selected or genetically modified to 
contain high isofiavone content will exist in the near future. Therefore, our 
observation that high dietary concentrations of genistein do not inhibit muscle growth 
in vivo is important. Thus, varieties of soybeans designed to contain high genistein 
concentrations would have at least equal value to normal soybeans as an amino acid 
source for pigs. 
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Tablet. Basal diet composition. 
Item Amount, % 
Com 36.45 
Soy protein concentrate 28.85 
Whey, dried 20.00 
Skim milk, dried 5.00 
Com oil 4.00 
Mono-dicalcium phosphate 2.89 
Limestone .23 
Sah .40 
L-lysine-HCl .20 
D,L-methionine .35 
L-threonine .20 
Tryptosine .15 
Vitamin-trace mineral mix'' .55 
Com starch .74 
Genistein source® — 
Analyzed composition 
Protein, % 27.62 
Fat, % 5.56 
Genistein; Total, ppm 79 
Normalized, ppm"^ 47 
Replaced com starch on a weight basis; Isoflavone composition of genistein source 
described in table 2. 
'Provided the following per kg of diet: Biotin, .30 mg; choline, 1800 mg; folic acid, 
1.80 mg; niacin, 90.0 mg; riboflavin, 21.0 mg; pantothenic acid, 60.0 mg; pyridoxine, 
9.0 mg; thiamine, 6.0 mg; Vit E, 96 lU; Vit A, 13,200 lU; Vit D3, 1323 lU; 
menadione, 3.0 mg; Vit B12, .105 mg; Cu, 17.5 mg; Fe, 175 mg; Mn, 60 mg; Se, .30 
mg; Zn, 150 mg. 
'^Conversion equation described in table 2. 
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Table 2. Isoflavone composition of genistein source. 
Isoflavone form Amount, mg/g Aglycone equivalents, mg/g^ 
Genistein form 
Genistin 714.13 462.56 
6"-0-acetylgenistin 0 0 
6"-0-Malonylgenistin 0 0 
Genistein 3.00 3.00 
Total genistein 717.13 465.56 
Daidzein form 
Daidzin 86.93 55.08 
6"-0-AcetyIdaidziii 0 0 
6"-0-Malonyldaidzin 0 0 
Daidzein 0 0 
Total daidzein 86.93 55.08 
Glycitein forms 
Glycitin 10.83 7.54 
6"-0-acetyIgIycitin 0 0 
6"-0-Malonylglycitin 0 0 
Glycitein 0 0 
Total glycitein 10.83 7.54 
Normalized amount = (molecular weight of aglycone form/molecular weight of 
glycosidic form)x mg of glycosidic form. 
Table 3. Efiecl of supplemental dietary genistein on serum AGP and isoflavone concentrations, and feed intake and rate and 
efllciency of growth in pigs fed from 4.5 to 27.7 kg BW. 
Supplemental genistein (G), ppm Probability® 
Item 0 200 400 600 800 CV, % GL GQ 
No. of pens 12 12 11 12 12 
Pig weight, kg 
Initial 4.67 4.65 4.56 4.45 4.59 15.9 .60 .71 
Final 27.46 27.72 27.96 27.75 27.71 6.5 .74 .59 
Serum isoflavone and AGP concentrations 
Genistein, |im .55 1.42 2.06 2.38 3.44 51.4 .01 .91 
Daidzein, )im .39 .50 .59 .71 .83 58.1 .01 .76 
AGP, }Ag/ml 563 640 599 654 601 10.2 .19 .05 
Pig growth and feed utilization 
BW gain, g/d 566 561 555 551 566 5.2 .77 .19 
Feed intake, g/d 689 681 704 679 677 7.1 .40 .65 
Gain: feed, g/kg 821 826 793 815 840 6.1 .42 .11 
®GL=linear etlect of genistein; GQ=quadratic effect of genistein 
Table 4. EfTect of supplemental dietary genistein on red and white muscle weights at 27.7 kg BW. 
Supplemental genistein, ppm Probability" 
Item 0 200 400 600 800 CV, % GL GQ 
Red muscle weights, g 
Psoas major 91 85 88 88 86 12.1 .52 .73 
Supraspinatus 19 21 22 22 20 15.9 .29 .01 
Triceps brachii 185 182 186 182 188 6.9 .61 .45 
Rectus femoris 115 117 116 116 119 7.5 .45 .86 
Total 410 404 413 408 412 5.2 .64 .76 
White muscle weights, g 
Longissimus dorsi 516 519 527 525 510 7.9 .86 .31 
Gluteus medius 169 168 166 164 172 5.9 .71 .12 
Semimembranosus 385 398 398 369 403 13.8 .87 .79 
Vastus lateralis 106 106 107 102 111 10.1 .52 .32 
Total 1175 1191 1198 1160 1197 6.7 .88 .99 
"01.= linear ellect ol genistein; quadratic ellect ol genistein. 
Table 5. Effect of supplemental dietary genistein on carcass weights and offal component weights in pigs fed from 4.5 to 27.7 kg 
BW." 
Supplemental genistein, ppm Probability" 
Item 0 200 400 600 800 CV, % GL GQ 
Carcass wt., kg 19.96 19.50 19.78 20.00 19.87 .85 .32 
Offal conponent weights, kg. 
Head 2.022 2.072 2.064 1.973 1.982 6.3 .12 .26 
Liver .743 .780 .743 .738 .738 10.1 .45 .65 
Kidney .143 .148 .144 .143 .143 11.1 .65 .76 
Heart-lungs .681 .666 .619 .608 .619 14.0 .04 .37 
GI tract 2.544 2.747 2.643 2.518 2.621 11.3 .75 .54 
Repro. tract .047 .041 .047 .043 .048 40.6 .75 .57 
''(jL= linear ettect ot genistem; quadratic ellect of genistein. 
Table 6. EfTect of supplemental dietary genistein on scrum genistein and daidzein concentrations. 
Supplemental genistein (G), ppm Probability*' 
Item 0 200 400 600 800 CV, % G L  G x D  
Serum genistein, |iM 
Day 8 .47 1.73 2.02 3.22 3.91 51.4 .01 .71 
Day 16 .97 1.18 2.41 2.21 3.33 
Day 24 .32 1.28 1.86 2.12 3.03 
Day 32 .47 1.46 1.95 1.98 3.51 
Serum daidzein, |.iM 
Day 8 .32 .54 .61 .94 .98 58.1 .01 .45 
Day 16 .48 .34 .72 .60 .96 
Day 24 .43 .57 .54 .70 .62 
Day 32 .34 .52 .50 .59 .78 
"Least squares means ot 8 sets ot 5 littermate barrows. 
^GL= linear effect of genistein. 
Table 7. EfTect of supplemental dietary genistein on feed intake and rate and efficiency of gain at 4 stages of growth". 
Supplemental genistein (G), ppm Probability 
Item BW, kg 0 200 400 600 800 CV, % GL GQ GQxBWL GQxBWQ 
BW gain, g/d 
4.5-10.5 435 376 372 368 375 12.1 .94 .92 ..31 .04 
10.5-16.5 534 591 584 561 591 
16.5-22.5 693 746 723 748 719 
22.5-28.5 796 764 791 771 783 
ike, g/d 
4.5-10.5 441 372 400 386 366 10.4 .61 .08 .01 .20 
10.5-16.5 635 665 658 648 660 
16.5-22.5 882 924 957 918 900 
22.5-28.5 1138 1160 1222 1160 1124 
Table 7. (con't) 
Supplemental genistein, ppm Probability 
Item BW, kg 0 200 400 600 800 CV, % GL GQ GQxBWL GQxBWQ 
Gain: feed, g/kg 
4.5-10.5 996 1016 938 958 1026 10.3 .58 .13 .22 .04 
10.5-16.5 846 891 891 871 900 
16.5-22.5 802 807 759 821 800 
22.5-28.5 699 659 647 673 702 
"Least squares means ot 12 sets ol 5 littermate barrows. to 
Table 8. Effect of supplemental dietary genistein on serum alpha-1 acid glycoprotein (AGP) concentrations. 
Supplemental genistein (G), ppm Probability 
Item 0 200 400 600 800 CV, % G G x D 
Serum AGP, |^g/ml 
DayO" 910 
Days'* 698 793 738 840 753 10.2 .05 Q .04 Q 
Day 16'' 578 719 662 739 673 
Day 24'' 505 552 527 566 504 
Day 32" 470 495 468 470 475 
'Least squares means often pigs prior to initiation ot experimental diets. 
''Least squares means of 12 sets of 5 litter mate barrows. 
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CHAPTER 5. EFFECTS OF DIETARY SOY ISOFLAVONE 
CONCENTRATIONS IN GRAVID RATS ON RATE AND EFFICIENCY OF 
GROWTH AND MUSCLE CONTENT OF THE OFFSPRING* 
A paper to be submitted to the Journal of Animal Science 
D.R. Cook", R.C. Ewan"', and T.S. Stahly^ 
Iowa State University, Ames, Iowa 50011 
Abstract 
Gravid rats were given ad libitum access to a basal, com-soy concentrate diet 
supplemented with 0, 431, 862, 1724 ppm soy isoflavones (42.3% genistein, 44.5 % 
daidzein, 13.2% glycitein) from mating through parturition. In experiment one, 
urinary daidzein and genistein recoveries from d 8-20 of gestation averaged 45% and 
17%, respectively. Both isoflavones were detected in fetal tissues indicating 
placental transfer had occurred. In experiment two, the dietary isoflavone 
concentrations consumed by the dam resulted in linear improvements (P < .09) in 
gain:feed ratio of male offspring fed a basal diet from weaning to 215 g BW but did 
not alter (P > .20) postoatal body growth rate nor daily feed intakes. Hind limb 
muscle weights and testicle weights increased quadratically (P < .03) as maternal 
dietary isoflavone intake increased but hind limb bone weights were 
'Research supported in part by the Iowa Soybean Association. The authors are 
CTateful for the assistance of Karen Langer in the collection of the data. 
Present address, Akey, Inc., 250 W. Clay St., C.S. 5002, Lewisburg, OH 45338. 
^Department of Animal Science, 337 Kildee Hall, Iowa State University, Ames, lA 
50011. 
•^To whom correspondence should be addressed. 
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not altered (P > .15). In female offspring, gain.feed ratios improved quadratically (P 
< .04) and body growth rate and feed intake increased linearly (P < .01) as maternal 
dietary isoflavone concentration increased. Hind limb muscle and bone weights were 
not altered (P > .1) but the protein content in hind limb muscle increased 
quadratically (P < .08). Based on these data, soy isoflavones fed to gravid rats 
increased muscle and testicular growth in male offspring and increased the rate and 
efficiency of growth in female offspring. These results are consistent with our data 
showing increased body and muscle growth rates in young pigs fed supplemental 
dietary isoflavones. 
Introduction 
Isoflavones are polyphenolic bioavailable compounds (Xu et al., 1994; Franke et 
al., 1995; King et al., 1996; Sfakianos et al., 1997) which occur in soybeans at 
concentrations as high as 5000 ppm (Kudou et al., 1991; Wang and Murphy, 1994a; 
Wang and Murphy, 1994b). In a previous paper (Chapter 3), we reported that dietary 
isoflavones fed to pigs from 6 to 30 kg BW increased muscle growth and the rate of 
BW gain. Muscle growth occurs through a process of myoblast proliferation and 
subsequent fusion to form muscle fibers. Altering certain factors during gestation, 
such as nutrient supply (Dwyer et al., 1993; Dwyer and Stickland, 1994; Dwyer et al., 
1994; Dwyer et al., 1995) hormone levels (Ogata et al., 1988; Bell et al., 1989), and 
the presence of noimutritive compounds (i.e. genistein) (Maltin et al., 1990; Kim et 
al., 1994), are reported to affect postnatal muscle growth potential. Some of 
isoflavones' biologic activities that could influence prenatal muscle development and 
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thus postnatal muscle growth include estrogenic effects (Medlock et al., 1995b; 
Santell et al., 1997; Zava and Duwe, 1997), immunomodulation (Trevillyan et al., 
1990; Wang et al., 1997; Zhang et al., 1997), inhibition of tyrosine kinase activity 
(Akiyama et al., 1987), inhibition of DNA synthesis in placental trophoblasts (Hamlin 
and Scares, 1995), and suppression of myoblast proliferation and differentiation 
(Hashimoto et al., 1995; Ji et al., 1997). Based on these data, isoflavones may impact 
a wide variety of biological processes including muscle growth and development. 
Therefore, our objective was to determine the effect of feeding soy isoflavones to 
gravid animals on postnatal rate and efficiency of growth and muscle content of the 
offspring. 
Materials and Methods 
Sprague-Dawley female rats were pair-mated with Sprague-Dawley males. Prior 
to mating, animals were allowed to consume a basal diet (Table 1) ad libitum. The 
morning a vaginal plug was detected (considered day 1 of pregnancy), male rats were 
removed and female rats were randomly allotted to the basal diet supplemented with 
0, 431, 862, or 1724 ppm isoflavones. The basal diet was formulated to meet or 
exceed the nutrient requirements of rats during gestation and lactation (NRC, 1995). 
The supplemental isoflavones were supplied by a soy extract (Archer Daniels 
Midland Co., Decatur, IL pilot extraction facility) that replaced com starch on an 
equal weight basis. The composition of the soy extract is described in Chapter 3, 
Table 2. The gravid females were allowed to consume feed and water ad libitum and 
were maintained on a 12 h light-dark cycle in a room sustained at 27 ° C. 
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Experiment one. Twenty, first-parity females (215 g BW) were penned 
individually in metabolism cages (circular, 30 cm diameter) fi-om d 6 to 20 of 
pregnancy. From d 8 to 20 post-mating, dam's feed intake (corrected for waste feed) 
and BW were measured every 2 d. Each dam's total 48 hr urine output also was 
collected every 2 d and stored at -20 ° C for subsequent analysis of genistein and 
daidzein concentrations. At d 20 postmating, rats were rendered imconcious via CO2 
inhalation and immediately decapitated. The conceptus tissues (uterine, placental, 
and fetuses) were separated and weighed to the nearest mg. Fetuses were cervically 
dislocated, fi-ozen in liquid nitrogen, and stored at -20 ° C for analysis of tissue 
isoflavone content. 
Experiment two. Eighty-five first and second parity females were peimed 
individually in wire-bottom cages (20 x 20 x 40 cm). At day 20 of gestation, dams 
were transferred to solid-bottom cages with wood shavings for whelping. 
Immediately after whelping, dams were allowed ad libitum access to the basal diet 
and water for lactation. Litter size was standardized to not more than seven pups on 
the day of whelping and to not more than six pups on day four of lactation by 
removing the largest and smallest pups fi^om each litter. Pups were not cross-
fostered. All litters were weaned at 20-23 days of age and one male and one female 
pup (close to the mean weight of the littter) per litter were individually penned in 
wire-bottom cages for a growth trial. Pups were given ad libitum access to a com-soy 
protein concentrate diet (Table 1) formulated to contain 1.4 % lysine and not less that 
108 
110 % of the ideal ratio other essential amino acids relative to lysine. The diet was 
formulated to meet or exceed nutrient requirements for growing rats (NRC, 1995). 
Dam BWs were measured at breeding and immediately following parturition, and 
dam feed intakes were quantified from d 1 of gestation through parturition. Litter 
weights were recorded within 3 hours after parturition and every four days throughout 
lactation. Following weaning, pup weights and feed disappearance were measured at 
four day intervals. All diets (gestation, lactation, and postweaning) were fed in meal 
form. 
At a BW of 215 ± 3 g, pups were anesthetized via CO2 inhalation and immediately 
decapitated. Feet and skin were removed from both hind limbs and the muscle and 
bones were removed at the hip joint. Hind limb muscle tissue was dissected free from 
the bone and weighed to the nearest mg, external fat was removed and placed with the 
carcass, and muscle was frozen at -20 ° C for subsequent protein analysis. Bone was 
weighed to the nearest mg and placed with the carcass. Internal organs of heart-
lungs, liver, kidneys, gastrointestinal tract, reproductive tract were weighed to the 
nearest mg and frozen for subsequent protein analysis. Hind limb feet and skin and 
the head all were stored with the carcass at - 20 ° C for subsequent Kjeldahl nitrogen 
analysis (AOAC, 1995). All animal procedures were approved by the Iowa State 
University Committee on Animal Care. 
Urinary and fetal tissue isoflavone concentrations were analyzed using 
modifications of the procedures reported by BCing et al. (1996) and Franke et al. 
(1995). Urine samples were thawed, centrifuged at 1000 x G for 20 minutes and 200 
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|i.L supernatant were placed in a 13 x 100 ram borosilicate glass tube (Fisher 
Scientific). Four-hundred |j.L of buffer (.17 M ammonium acetate, pH 4.6 containing 
1.67 ml Beta-glucuronidase-sulfatase/100ml) was mixed thoroughly with the urine 
and the tubes were covered with parafilm and incubated a minimum of eight hours at 
37 C. The urine-ammonium acetate mixture was then extracted twice by adding 1.0 
ml of diethyl ether to each tube, vortexing gently, centrifuging at 1000 x g for 15 min, 
and transferring ether to another tube. Ether was then evaporated under a stream of 
nitrogen and dried residue was dissolved in 200 ^1 of 80% aqueous methanol. Fifty 
ial was injected for liquid chromatographic quantification. 
The HPLC conditions were as follows: The column was a 3.9 x 300 mm C'^ 
Bondapak with a pore size of 10 |im. Mobile phase A consisted of HPLC grade 
methanol and mobile phase B consisted of 0.1 M ammonium acetate, pH 4.6 and 25 
mM EDTA in a 50:1 ratio. Gradient elution was utilized in the following manner: 
42.5% to 52% mobile phase A in B from injection to 17.1 minutes, then 60% A to 25 
minutes and 42.5% A in B to 30 minutes at a flow rate of 1.0 ml/min. In this system, 
daidzein eluted at approximately 15.1 min and genistein eluted at approximately 21.0 
min. Dual beam spectrophotometric detection was used at a wavelength of 260 nm 
and an AFU setting of .08. Standards consisting of 12.5, 25, 50, 100, 200, 300, 400, 
and 500 (iM daidzein and genistein in 80% aqueous methanol were used to calculate 
a standard curve using peak area. 
For fetal tissue analysis, fetuses were frozen in liquid nitrogen and powdered 
under liquid nitrogen in a blender. Samples weighing approximately 2.0 g were 
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homogenized in 20 ml of l.O mM Tris, 1.5 nM EDTA, pH 7.4. Homogentes were 
mixed with .17 M ammonium acetate buffer, pH 4.6, containing 1.67 ml beta-
glucuronidase per 100 ml. Samples were incubated a minimum of 8 h at 37 C, then 
extracted once with 25 ml diethyl ether. Ether was transferred to 50 ml erlenmeyer 
flasks and evaporated until 2-3 ml remained. The remaining ether was transferred to 
13x100 mm borosilicate tubes and evaporated to dryness. Residues were dissolved in 
200 |il 80% aqueous methanol, centrifuged at 850 x G for 15 minutes, and 50 |il 
supernatant was injected for liquid chromatographic analysis as described above. 
Using these procedures, the sensitivity was approximately .4 |ig/ml, and percent 
recoveries for daidzein and genistein were 94.5 and 104.1 with intra-assay CVs of 7.4 
and 7.8 %, respectively. 
Data were analyzed by variance techniques using the GLM procediu-e of SAS, 
(1997). Data were analyzed as a completely randomized design and dam was 
considered the experimental unit. The orthogonal linear, quadratic, and cubic 
contrasts were used to evaluate the response to dietary isoflavone concentrations. 
Coefficients for geometrically increasing levels (0, IX, 2X, 4X) were utilized. 
Carcass weight was used as a covariate for the analysis of offspring muscle and bone 
weights, and muscle and carcass protein. Pup BW gain/d, feed intake/d, and 
gainrfeed ratios over four stages of growth postweaning were analyzed via a repeated 
measiires analysis. Separate analyses were performed for male and female pups 
postweaning as a result of large differences in growth rate and efficiency of feed 
utilization. All data presented are least squares means. 
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Results 
Diets. The basal diet contained 149 ppm total isoflavones and the diets 
supplemented with 431, 862 and 1724 ppm diets contained 582, 1023, and 1941 ppm 
total isoflavones, respectively (Table 2). 
Experiment one. 
Growth and Tissues Increasing dietary dam isoflavone levels decreased dam 
feed intake and BW (Table 4) linearly (P < .01). As expected, feed intake and BW 
increased with increasing days of gestation (P < .01). Total conceptus weights, litter 
weights, placental weights, and uterine weights were not altered (P >.1) by the dam's 
isoflavone level (Table 3). Fetal number, and placenta weight/fetus were also not 
altered by isoflavone regimen (P > .1) 
Urinary and tissue isoflavones Percent urinary recovery of daidzein (Table 5) 
increased quadratically (P < .01) with increasing isoflavone level and percent urinary 
recovery of genistein (Table 5) responded in a cubic fashion (P < .02). Daidzein 
recovery did not change (P > .1) over time but genistein recovery decreased (P < .01) 
with increasing day of gestation. Fetal tissue isoflavone levels were below the 
detection limit of our assay (.4 nM) with the exception of the highest isoflavone level. 
Daidzein and genistein were detected in fetal tissue from all rat dams consuming the 
highest isoflavone level and averaged .78 and .80 )iM, respectively. 
Experiment two. 
Gestation The initial BW of rat dams at breeding averaged 270 g (Table 8). 
During gestation, isoflavones decreased feed intake, and thus post partum BW, 
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linearly (P < .01). However, total pups bom and pup birth weight were not altered (P 
> .1) in response to isoflavones 
Lactation Dam feed intake and pup BW gain from parturition to weaning were 
not altered by maternal isoflavone intake (P > .1). Although post-partum BW of 
dams decreased linearly in response to isoflavones (Table 7), BW change was not 
altered (P > .1) in response to dietary treatments at any stage of lactation (Table 6). 
Dam feed intake (Table 7) from d 4-8 of lactation was decreased at the lowest level of 
supplemental isoflavones, then increased in response to higher levels of isoflavones 
resulting in a quadratic response (P < .05). 
After adjustment on d 4, litter size was not significantly different between 
treatments (P > . 1) indicating litter size was successfully standardized. Average pup 
BW gain during lactation (Table 8) was decreased (P < .09) at 4-8 and 8-12 d of 
lactation with increasing dam isoflavone intake. 
Postweaning Male pups daily BW gains and feed intakes (Table 9) were not 
altered (P > .1) by maternal isoflavone intake but gain:feed ratios increased linearly as 
isoflavone level increased (P < .08). The impact of maternal isoflavone intake on 
daily BW gain, daily feed intake, and gain:feed ratios (Tables 10, 11, and 12) was not 
dependent (P > .1) on the male offspring's stage of growth. 
Female daily BW gains and feed intakes (Table 9) were increased linearly (P < 
.01) and gain: feed ratios increased quadratically (P < .04) as the dam's isoflavone 
level increased. Similar to responses in male pups, effects of matemal isoflavone 
intakes on female offsprings' growth, feed intakes, and efficiencies of feed utilization 
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were not dependent (P > .1) on the female pups' stage of growth (Tables 10, II, and 
12). 
Body tissues Ai slaughter, carcass weights (Table 13) averaged 142 and 148 g in 
male and female offspring and were not altered by isoflavone level (P > .1). As the 
dam's isoflavone intake increased, muscle weights increased quadratically (P < .05) in 
male, but not in female pups. Bone weights were not altered (P > . 1) in either gender 
by the dam's isoflavone intake. 
Offal component weights of liver, kidney, and heartlungs in male and female pups 
(Table 14) were not altered (P > .1) by isoflavone level. Weights of reproductive 
organs increased quadratically (P < .01) in male but not in female pups in response to 
increasing maternal isoflavone intake. 
Total hind limb muscle protein and total body protein content increased 
quadratically (P < .04, P < .09, respectively), in male pups but were not altered (P > 
. 1) in female pups as maternal isoflavone intake increased. Visceral protein content 
responded in a cubic fashion (P < .01) in male pups and increased linearly (P < .06) in 
female pups with increasing maternal isoflavone level. Carcass protein was not 
altered (P > .1) in male pups but increased quadratically (P < .05) in female pups with 
increasing maternal isoflavone intake. 
Discussion 
Our data indicate that both daidzein and genistein (based on urinary recoveries), 
from the isoflavone source in this study, were bioavailable to gravid rats. In addition, 
fetal tissues with detectable levels of genistein and daidzein suggest that both 
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isoflavones crossed the placenta. Thus, fetuses were directly exposed to isoflavones 
which establishes a basis for isoflavone-induced changes in postnatal muscle growth 
as a result of maternal isoflavone intake during pregnancy. 
Numerous studies suggest altered fetal muscle development can impact postnatal 
growth (Ashmore et al., 1974; Ezekwe and Martin, 1975; Powell and Aberle, 1975; 
Fowler et al., 1980; Handel and Stickland, 1988; McFarland et al., 1993; Kimet al., 
1994). Critical processes occur during fetal development that affect postnatal muscle 
growth potential of the offspring. Specifically, that rate of fetal myoblast 
proliferation and subsequent extent of muscle fiber formation determine muscularity 
in mature animals. Thus, manipulation of factors which influence fetal muscle 
development, such as nutrient supply (Dwyeret al., 1993; Dwyer and Stickland, 1994; 
Dwyeret al., 1994; Dwyeret al., 1995), hormone levels (Ogataet al., 1988; Bellet al., 
1989), and the presence of nonnutritive compounds (i.e. genistein) (Maltinet al., 
1990; Kimet al., 1994), likely will affect postnatal muscle growth potential. 
In the current study, hind limb muscle weights of male rats increased in response 
to increasing maternal dietary isoflavone level during gestation, but bone weights 
were not different. In a previous smdy at our station, isoflavones firom the same soy 
extract increased muscle growth when fed to young pigs. The muscle growth 
response in the current study was paralleled by an increase in testicle weight 
suggesting that changes in muscle may have been related to altered androgen levels 
and the anabolic effects of androgens. Isoflavones have recently been shown to 
inhibit thyroid hormone production (Divi et al., 1997). Neonatal hypothyroidism in 
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male rats increases both Leydig and Sertoli cell proliferation (Hardy et a'., 1996) 
resulting in greater numbers of these cells in adults and thus, greater number of cells 
capable of producing testosterone. Also, genistein inhibits 5a-reductase activity 
which converts testosterone to dihydrotestosterone (Evans et al., 1995). The direct 
impact of this alteration on testicular development in a fetus is not clear. However, it 
is clear that genistein has the ability to alter steroid hormone metabolism, and the 
response of hind limb muscle weights in males was paralleled by testicular weights 
suggesting that isoflavones may have altered muscle weights in male rats by 
impacting steroid hormone metabolism and testicular development. 
In female rats, hind limb muscle weights were not altered by maternal dietary 
isoflavones, but muscle, carcass, and total body protein increased slighlty suggesting 
a generalized anabolic effect. Increased hindlimb muscle in male but not female 
offspring suggests isoflavones' mode of action may not be a direct effect on 
developing muscle, but rather, an indirect effect via a gender-dependent mechanism 
(i.e. altered androgen levels). Thus, the impact of fetal exposure to isoflavones on 
muscle growth postnatally in castrated animals would be valuable information. 
However, the pattern of responses in males point to an effect specific to muscle tissue 
as opposed to bone or skin. Hind limb muscle and protein contents were increased 
whereas bone weights and total carcass protein were not altered. A lack of effect on 
total carcass protein likely represents a dilution effect of non-muscle proteinacious 
tissues on the increased muscle protein when analyzed together. 
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Although not analyzed in this study, percent body protein of female rats seemed to 
be higher than males. This is consistent with previous data in rats showing greater 
percentage body fat in male vs female rats (Perry et al., 1979; Spencer and Robinson, 
1992). 
In females, increasing maternal isoflavone intake improved growth rate and 
efficiency of feed utilization. The majority of the response seemed to be in pups from 
dams fed the highest isoflavone level which gained BW 15% faster than control pups 
and had gain:feed ratios 10% greater than control pups. The response was consistent 
during four stages of growth. When administered from d 1-5 postnatally, the 
estrogenic compound coumesterol has been reported to decrease estrogen receptor 
levels in growing female rats (Medlock et al., 1995a). As mentioned earlier, 
exogenous estrogen decreases feed intake in rats. Exposure to isoflavones during 
fetal development might have lowered estrogen receptor expression postnatally. 
Decreased responsiveness to endogenous estrogens postnatally might then allow 
increased feed intake in female offspring. We did not, however, quantify estrogen 
receptor expression in response to prenatal administration of isoflavones. Based on 
these data, the level of dietary isoflavones consiuned by dams during pregnancy has a 
permanent effect of the offspring's postweaning rate of feed intake and body and 
muscle growth. 
Dietary isoflavones fed to gravid rats decreased maternal food intake during 
gestation but did not alter number of pups bom or birth weight suggesting that the 
reduction in food intake (10.4 %) was not large enough to be detrimental for fetal 
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growth and survival. Dietary estrogens previously have been reported to decrease 
feed intake in rats (Moffit et al., 1975). Thus it seems likely that isoflavone-mediated 
reductions in feed intake are a result of dietary estrogenic activity. In addition, 
isoflavones are reported to have a bitter taste suggesting that palatability also could 
have played a role in reduced feed intake (Cook and Samman, 1996). 
In addition to a reduction in food intake during gestation, maternal BW at 
parturition decreased linearly with increasing dietary isoflavones. But by d 4 of 
lactation, no differences in maternal BW were detected, and feed intake from 
parturition to d 4 of lactation did not differ among treatments. This discrepancy may 
be related to hydration level of dams during isoflavone consumption. In experiment 
one, mine volume increased with increasing dietary isoflavone levels (data not 
shown). In fact, urine volume of rats on the highest level of isoflavones was twice 
that of control rats. Genistein has a salidiuretic action in isolated perfused rat kidneys 
which results in diuresis when genistein is administerd in vivo (Gimenez et al., 1998). 
Thus rats consuming large amounts of genistein may have been dehydrated until 
shortly after parturition at which time, all rats received the basal diet with a low level 
of genistein. Removal of genistein would then allow rehydration and a rapid increase 
in BW. However, the reduction in maternal food intake cannot be ignored. Although 
not statistically different, the mean weight of dams fed the highest isoflavone level 
was 8 g less than control dams at d 4 of lactation. Thus maternal body energy stores 
and milk output potential may have been decreased. 
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Litter size was standardized to not more than six pups early in lactation in an 
attempt to minimize potential confounding effects isoflavones could have on 
mammary development, matemal body energy stores, and thus milk output. Even so, 
pup BW gain from d 4-12 was decreased with increasing isoflavone level. But after d 
12 of lactation, pup BW gain was not altered. Rat pups begin to open their eyes 
around 10-12 days of age and start consvmiing matemal food shortly thereafter. Thus 
decreased pup BW gain early in lactation, followed by a lack of difference in late 
lactation may reflect reduced maternal body energy stores and decreased milk output 
as a result of decreased gestational maternal feed intake. Upon consimiption of 
matemal food around d 12 of lactation, rat pups could alleviate their dietary 
restriction by consuming matemal feed. Rat dams restricted to 75% of ad libitum 
intake during gestation had pups at d 14 of lactation that were 20% lighter than 
controls (Young and Rasmussen, 1985). Our data are consistent with this observation 
becasuse a 10% reduction in matemal food intake during gestation was associated 
with a 10% reduction in the rate of pup BW gain from d 8-12 of lactation. 
Urinary daidzein and genistein recoveries averaged 45 and 17% respectively 
pooled across time. King et al. (1996) reported 17% urinary recovery of genistien in 
rats that received a bolus dose of either aglycone genistein or soy extract. Initial 
plasma concentrations of genistein were almost three-fold greater in rats that received 
the aglycone form of genistein vs the glycosidic form in the soy extract. However, 
plasma concentrations from 4-24 h post administration did not differ suggesting 
glycosidic genistein has a similar bioavialability as aglycone genistein. Greater 
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bioavailability of daidzein relative to genistein based on urinary excretion has been 
reported previously in humans (Xu et al., 1994; Xu et al., 1995) and suggested to be 
partly a result of shorter intestinal half live for gensitein relative to daidzein. 
However, plasma concentrations of daidzein and genistein in these studies did not 
differ and thus do not support greater bioavailabilities of daidzein. Our data indicate 
that daidzein and genistein do cross the placenta and are found in fetal tissue in 
similar proportions relative to their dietary concentrations. Unfortunately, only 
fetuses from dams fed the highest dietary concentration of isoflavones had detectable 
tissue isoflavone levels and thus, the dose-dependency of isoflavone placental 
transfer is not apparent from our data. 
Daidzein recoveries did not change with increasing day of gestation while 
genistein recoveries decreased. Conflicting reports exist on changes in isoflavone 
excretion with chronic isoflavone consumption, however, few studies exist (Lu et al., 
1995; Lu et al., 1996). Altered rates of urinary genistein excretion with chronic 
consumption could indicate bacterial adaptation in the intestines and increased 
bacterial degradation of genistein. However, in a previous study with pigs (Chapter 
4), serum genistein levels over a 24 d feeding trial were not altered. Thus, decreased 
urinary output may indicate a change in the relative routes of excretion (i.e. biliary vs 
urinary). In support of this, fetal tissue levels of daidzein and genistein were similar 
after 12 d of isoflavone consumption by rat dams suggesting fetuses were exposed to 
similar levels of dadizein and genistein. 
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In conclusion, dietary isoflavones consumed by gravid rats are absorbed, cross the 
placenta, and impact fetal development resulting in altered rates of postnatal body and 
muscle growth in the offspring. These changes seem to be consistent with 
documented effects of isoflavones and estrogenic compounds on perinatal 
develpment. Our data on relative urinary excretion of daidzein vs genistein are 
consistent with other studies in that daidzein excretion through the urine seems to be 
greater than gensitein when similar doses are consumed. Further, similar 
concentrations of daidzein and genistein in fetal tissue suggest similar 
bioavailabilities of genistein and dadzein. 
Implications 
Dietary isoflavones, when fed to gravid animals, can impact postnatal growth and 
muscle content of the offspring. The observations that isoflavones have a plethora of 
biological activities, cross the placenta, and impact postnatal muscle growth 
responses, suggest that high isoflavone intakes during gestation in other livestock 
species may alter other responses which merit investigation. Elucidation and 
quantification of these responses will allow manipulation of dietary isoflavone levels 
via novel soy processing techniques or genetic manipulation of soybeans, to optimize 
performance criteria in livestock. 
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Table 1. Composition of basal diets, %. 
Stage of growth 
Item Dam, gestation/lactation Offspring, postnatal growth 
Com, ground 67.67 60.96 
Soy protein concentrate 23.20 31.19 
Com oil 4.00 4.00 
Mono-dicalcium phosphate 1.81 .46 
Limestone .91 .88 
Salt .20 .20 
D,L-methiomne .55 .80 
Premix'' .91 .76 
Com Starch .75 .75 
Soy extract^ — — 
Analyzed composition 
Protein, % 21.35 26.06 
Fat, % 6.36 6.11 
Soy extract described in table 2. 
''Contributed the following per kg of maternal diet: Biotin, .60 mg; choline, 2250 mg; 
folic acid, 3.0 mg; niacin, 45.5 mg; riboflavin, 12.0 mg; pantothenic acid, 30.0 mg; 
pyridoxine, 18.0 mg; thiamine, 12.0 mg; Vit E, 81 lU; Vit A, 6900 lU; Vit D3, 3000 
lU; menadione, 3.0 mg; Vit B12, .15 mg; Cu, 17.5 mg; Fe, 175 mg; Mn, 60 mg; Se, 
.36 mg; Zn, 150 mg; 
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Table 2. Analyzed isoflavone composition of dam's experimental diets. 
Supplemental isoflavones. ppm® 
Item 0 431 862 1724 
Total isoflavones, ppm*" 
Daidzein 50 249 460 886 
Genistein 84 263 464 868 
Glycitein 16 59 100 182 
Total 150 571 1024 1936 
Normalized'^ 
Daidzein 28 153 277 538 
Genistein 47 159 288 542 
Glycitein 8 41 66 116 
Total 83 353 631 1196 
Supplemental isoflavones supplied by a soy extract described in Chapter 3. 
""Total of glycosidic and aglycone forms. 
•^Total amount normalized to molecular weight of aglycone forms. 
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Table 3. (Exp. 1) Effect of dam's isoflavone regimen on BWs and reproductive tissue 
weights of gravid rats. 
Dan. s isoflavone regimen, ppm Probability 
Item 0 431 862 1724 CV, % Isoflavone 
No. of pens 5 6 4 5 
Dam BW, g - day of gestation 
d8 232.5 236.7 229.6 227.6 3.4 .16 
d20 334.3 342.3 321.4 311.2 6.1 .04L 
Reproductive tissue weights, g 
Fetuses 53.76 52.82 50.73 51.35 27.7 .86 
Placental 11.05 11.28 10.24 10.91 21.3 .53 
Uterine 4.59 4.64 4.08 3.98 17.8 .16 
Placental 
wt./fetal wt. 
.21 .21 .20 .26 30.0 .21 
Fetal no. 13.25 13.33 11.75 12.40 25.7 .57 
Table 4. (Exp. 1) Efiect of dam's isoflavone regimen on feed intake and BW gain of gravid rats at six, 2-d periods during 
gestation. 
Item 
Days of Dam's isoflaovne regimen, ppm Probability 
Gestation 0 431 862 1724 CV, % Isoflavone® Day Iso X Day 
Feed intake, g 8-10 34.3 34.8 32.8 32.1 11.5 .OIL .01 .78 
10-12 36.1 37.6 34.3 31.9 
12-14 40.2 36.5 34.3 33.1 
14-16 36.3 38.2 37.3 35.0 
16-18 42.3 43.9 39.8 39.8 
18-20 40.2 42.2 37.9 32.4 
BW gain, g 8-10 11.5 11.8 11.3 10.0 5.1 .OIC .01 .99 
10-12 2.0 9.4 6.5 4.4 
12-14 6.0 11.6 10.0 10.5 
14-16 17.6 19.4 19.8 17.9 
16-18 27.2 25.8 21.2 25.2 
18-20 24.7 22.8 23.0 15.6 
''L=linear; C=cubic. 
Table 5. (Exp. 1) Effect of dam's isoflavone regimen on percentage urinary daidzein and genistein recovery of gravid rats at 
six, 2-d periods during gestation. 
Item 
Days of Supplemental isoflaovne regimen, ppm Probability 
Gestation 0 431 862 1724 CV, % Isoflavone® Day Iso X Day 
Daidzein, % 8-10 25.9 45.1 50.3 67.9 37.0 .OIQ .22 .23 
10-12 29.3 51.6 66.4 54.4 
12-14 23.9 58.7 57.6 57.7 
14-16 26.9 55.1 51.4 44.0 
16-18 24.5 34.5 43.3 54.8 
18-20 14.6 41.2 37.5 68.9 
Genistein, % 8-10 8.1 25.9 22.3 34.2 46.7 .02C .01 .70 
10-12 8.2 25.0 25.5 26.0 
12-14 7.0 21.1 22.1 24.0 
14-16 7.7 19.5 19.3 17.0 
16-18 6.4 13.0 15.3 19.4 
18-20 3.6 10.3 13.5 19.4 
"Q=quadratic; C=cubic. 
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Table 6. (Exp. 2) Effect of dam's isoflavone regimen on body weights® and feed intakes® 
of gravid dams, litter size,® and pup body weights at parturition'' and weaning.® 
Dam's isoflavone regimen, ppm Probability 
Item 0 431 862 1724 CV, % Isoflavone*^ 
Dam's data, mating to parturition 
No. of dams 20 25 24 20 
BW 
Breeding, g 267.0 275.6 270.5 269.8 5.2 .64 
Parturition, g 304.2 312.9 300.3 292.3 5.9 -OIL 
Feed,g 405.6 407.3 398.9 363.5 6.7 .OIL 
Litter data at birth 
Total bom 12.6 12.3 12.9 11.4 24.7 .48 
Litter wt., g 73.8 71.5 75.5 64.3 21.9 .46 
Pup wt., g 5.89 5.88 5.90 5.75 8.9 .27 
Litter size, d 0® 6.63 5.70 6.63 6.47 19.4 .OIC 
Litter data after litter size standardized'' 
No. of pens 20 25 24 20 
Litter size, d 4 5.88 5.08 5.83 5.77 34.3 .13 
Litter size, wean 5.28 4.54 5.04 5.01 32.2 .32 
Pup wean wt., g 57.41 56.87 56.37 56.47 11.9 .17 
Daily BW gain, g 2.73 2.66 2.59 2.64 10.5 .20 
Litter size standardized to not more than 7 pups. 
''Litter size standardized to not more than 6 pups. 
'^L=linear; C=cubic. 
Table 7. (Exp. 2) Effect of dam's isoflavone regimen on dam feed intake and BW gain at 6 stages of lactation. 
Day of 
Item 
Dam's isoflavone regimen, ppm Probability 
Lactation 0 431 862 1724 CV, % Isoflavone" 
0-4 92.3 81.1 92.1 93.3 25.8 .61 
4-8 149.3 136.1 138.5 151.9 20.9 .06Q 
8-12 186.4 160.5 168.2 166.0 22.8 .17 
12-16 190.9 186.3 189.3 187.7 25.8 .61 
16-20 203.9 196.8 205.7 212.1 28.2 .54 
0-wean 984.4 956.3 1004.3 985.2 24.9 .49 
0-4 9.2 3.3 7.4 13.5 6.1 .20 
4-8 13.5 15.3 17.0 17.2 5.5 .48 
8-12 6.5 7.5 7.5 10.5 5.4 .68 
12-16 1.4 -.6 .4 .4 5.3 .56 
16-20 -11.1 -9.1 -8.8 -9.4 5.6 .79 
0-wean 14.3 9.4 14.2 24.4 6.0 .46 
Dam feed intake, g 
BW change, g 
''L=Unear; Q=quadratic. 
Table 8. (Exp. 2) EfTect of dam's isoflavone regimen on pup BW gain at 5 stages of lactation. 
Day of Supplemental isoflavone regimen, ppm Probability 
Item Lactation 0 431 862 1724 CV, % Isoflavone" 
BW gain, g 0-4 1.25 1.15 1.17 1.22 26.0 .27 
4-8 2.49 2.36 2.22 2.37 19.3 .090 
8-12 3.23 3.13 3.05 2.92 16.0 .05L 
12-16 3.07 3.10 3.02 3.17 12.0 .40 
16-20 3.16 3.08 3.00 3.10 10.6 .15 
''L=linear; Q=quadratic. 
U) K) 
Table 9. (Exp. 2) Effect of dam's isoflavone regimen on feed intake and rate and efficiency of growth 
in male and female offspring. 
Dam's isoflavone regimen, ppm 
Item 0 431 862 1724 CV, % 
11.8 
2.3 
5.9 
7.8 
6.8 
12.1 
2.5 
4.6 
16.3 
13.2 
Probability 
Isoflavone® 
.43 
.08Q 
.13 
.53 
.08L 
Males 
Pup BW, g 
Initial 66.0 66.1 65.7 67.2 
Final 215.2 215.3 218.3 215.7 
Pup growth and feed utilization 
Feed.g/d 14.17 14.03 13.83 13.77 
BWgain,g/d 5.87 5.84 5.79 5.89 
Gain: feed, g/kg 414 416 419 428 
Females 
Pup BW, g 
Initial 63.2 62.3 63.7 62.5 
Final 214.1 214.0 212.6 216.2 
Pup growth and feed utilization 
Feed,g/d 12.71 12.88 12.91 13.28 
BWgain, g/d 2.69 2.76 2.63 3.12 
Gain: feed, g/kg 211 214 203 234 
''L=linear; Q=quadratic. 
.61 
.15 
.OIL 
.OIL 
.04Q 
Table 10. (Exp. 2) Effect of dam's isoflavone regimen on daily feed intake of male and female offspring at 4 stages of 
growth. 
Pup Dam's isoflavone regimen, ppm Probability 
Item BW, g 0 431 862 1724 CV, % Isoflavone"" 
Males 
Daily feed, g wean-98 9.17 9.20 9.08 8.95 
98-131 12.82 12.37 12.78 12.62 
131-163 15.38 15.41 14.98 15.24 
163-195 17.60 17.44 16.89 17.65 
Females 
Daily feed, g wean-98 8.82 8.85 8.89 9.10 
98-131 12.69 12.79 12.61 12.62 
131-163 14.35 14.37 14.26 14.97 
163-195 13.86 14.06 14.27 14.80 
"No isoflavone by BW interaction detected (P >. 10) ibr male or females. 
''Q=quadratic. 
Table 11. (Exp. 2) EfTecl of dam's isoflavone regimen on BW gain of male and female offspring at 4 stages of 
poslweaning growth. 
Pup Dam's isoflavone regimen, ppm Probability 
Item BW,g 0 431 862 1724 CV, % Isoflavone"^ 
Males 
BW gain, g/d wean-98 4.26 4.28 4.33 4.25 17.2 .43 
98-131 6.28 6.07 6.28 5.90 
131-163 6.86 7.12 6.70 7.00 
163-195 7.82 7.08 6.65 7.46 
Females 
BW gain, g/d wean-98 3.58 3.67 3.68 3.81 21.0 .OIQ 
98-131 4.47 4.48 4.32 5.03 
131-163 3.20 3.30 3.06 3.64 
163-195 2.50 2.20 2.28 2.75 
"No isoflavone by BW interaction detected (P > . 10) lor male or female pups. 
''Q=quadratic. 
Table 12. (Exp. 2) Effect of dam's isoflavone regimen on gain; feed ratios of male and female offspring at 4 stages of 
growth. 
Pup Dam's isoflavone regimen, ppm Probability 
Item BW,g 0 431 862 1724 CV, % Isoflavone"^ 
Males 
Gain: feed, g/kg wean-98 464 466 476 473 17.6 .69 
98-131 489 510 492 468 
131-163 445 463 451 458 
163-195 439 405 389 423 
Females 
Gain: feed, g/kg wean-98 407 415 414 420 16.7 .OIQ 
98-131 355 351 343 397 
131-163 222 229 214 240 
163-195 180 154 158 184 
"No isotlavone by BW interaction detected (P >. 10) for male or temaie pups. 
^Q=quadratic. 
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Table 13. (Exp. 2) Effect of dam's isoflavone regimen on carcass, head, and hindlimb 
bone and muscle weights in male and female offspring®. 
Dam's isoflavone regimen, ppm Probability 
Item 0 431 862 1724 CV, % Isoflavone*^ 
Males 
Carcass wt., g 142.62 142.62 142.72 142.03 2.5 .25 
Head wt., g 17.01 17.27 16.77 17.11 4.6 .06C 
Bone wt., g 3.21 3.27 3.22 3.23 7.5 .17 
Muscle wt., g 22.65 22.96 23.24 22.74 6.1 .03Q 
Females 
Carcass wt., g 148.54 149.04 147.42 149.18 2.4 .17 
Head wt., g 18.43 18.54 18.61 18.44 4.2 .42 
Bone wt., g 3.37 3.39 3.41 3.34 4.3 .27 
Muscle Avt., g 26.47 26.41 26.59 26.30 3.7 .56 
Carcass weight used as a covariate. 
'^Q=quadratic; C=cubic. 
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Table 14. (Exp. 2) Effect of dam's isoflavone regimen on offal component and 
reproductive tract weights in male and female offspring. 
Item 
Dam's isoflavone regimen, ppm Probability 
0 431 862 1724 CV, % Isoflavone^ 
Males 
Liver wt., g 9.64 9.59 9.76 9.57 7.0 .61 
Kidney wt., g 1.91 1.95 1.92 1.92 5.4 .36 
Heart/lung wt., g 2.56 2.45 2.53 2.50 8.8 .13 
GI tract wt., g 20.99 20.72 22.25 21.71 9.8 .08C 
Testicle wt., g 4.50 4.76 4.84 4.72 7.6 .OIQ 
Females 
Liver wt., g 7.15 7.12 7.16 7.19 8.1 .81 
Kidney wt., g 1.67 1.66 1.66 1.63 5.7 .12 
Heart/lung wt., g 2.33 2.36 2.33 2.36 7.5 .63 
GI tract wt., g 17.63 17.25 17.53 18.44 6.1 .03Q 
Uterine/ovary wt., g .85 .90 .82 .95 36.1 .33 
Q=quadratic; C=cubic. 
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Table 15. (Exp. 2) Effect of dam's isoflavone regimen on protein percentage and content 
of carcass, muscle and viscera in male and female offspring. 
Item 
Dam's isoflavone regimen, ppm Probability 
0 431 862 1724 CV, % Isoflavone*^ 
Males 
Carcass protein, g®*^ 37.42 37.76 37.94 37.82 3.0 .24 
Muscle protein, g'^ 5.02 5.13 5.16 5.05 4.6 .04Q 
Visceral protein, g 5.86 5.79 6.15 5.93 5.4 .OIC 
Total protein, g*" 43.28 43.56 44.09 43.75 2.7 .09Q 
Female 
Carcass protein, g®"^ 38.47 38.92 39.02 38.65 2.7 .07Q 
Muscle protein, g' 6.15 6.24 6.25 6.12 4.7 .11 
Visceral protein, g 4.53 4.51 4.49 4.67 5.4 .06L 
Total protein, g*" 43.00 43.43 43.51 43.32 2.4 .14 
Includes muscle protein. 
''Sum of carcass and viscera. 
'^Carcass weight used as a covariate. 
'^L=linear; Q=quadratic; C=cubic. 
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CHAPTER 6. GENERAL CONCLUSIONS 
Based on the data presented in this dissertation, soybean isoflavones are 
bioavailable to pigs and rats, and have biological effects on pre and postnatal muscle 
growth. Isoflavone absorption in pigs and rats is dose-dependent at the 
concentrations tested and thus, increasing dietary isoflavone levels will result in 
greater serum and urinary concentrations. Increased muscle growth in pigs 
postnatally in response to isoflavones seems to be dependent on the predominant 
metabolic fiber type present in the muscles. Thus, it may be possible to selectively 
alter red vs white muscle growth with dietary isoflavones and increase the value of 
carcasses based on their red vs white muscle content. Because increased muscle 
growth was only observed in pigs consuming a mixtiu-e of isoflavones in relative 
proportions to isoflavones found in soybeans, but not in pigs consuming diets 
supplemented primarily with genistein, it seems likely that genistein alone does not 
affect muscle growth in vivo. Therefore, serum genistein concentrations 3.5 fold 
greater than are required to inhibit muscle growth responses in vitro do not affect 
muscle growth in vivo. Increased muscle growth in response to a mixture of 
isoflavones indicates that another isoflavone has a positive effect on muscle growth. 
Based on data which demonstrate that daidzein has the ability to modulate immune 
and metabolic responses, it seems likely that daidzein is the isoflavone responsible 
for altered muscle growth. 
Daidzein and genistein both have the ability to cross the placenta and are thus 
bioavailable to the fetus. Thus, altered postnatal muscle and organ growth of animals 
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in response to dietary maternal isoflavones could be a result of direct isoflavone 
action on the developing fetus. Alternatively, isoflavones could alter maternal 
metabolism or hormones which are anabolic for the fetus and thus indirectly alter 
fetal development and thus, postnatal growth. 
The data presented in this dissertation indicate that isoflavones are bioavailable to 
pigs and rats, can cross the placenta, and can affect posmatal growth when fed either 
during gestation, or during postnatal growth. Because soy products are a major 
source of feed ingredients for livestock, elucidation of which isoflavone is responsible 
for altered muscle growth and determining its mode of action are important steps for 
increasing the value of soy products as feed ingredients for pigs. 
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